UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the quarterly period ended September 28, 2019October 3, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  
For the transition period from _____to _____
Commission File Number 001-36801
qorvoform8kimagefinala67.jpg
Qorvo, Inc.
(Exact name of registrant as specified in its charter) 
Delaware 46-5288992
(State or other jurisdiction of incorporation or organization) (I.R.S. employer identification no.)
   
7628 Thorndike Road  
Greensboro,North Carolina 27409-9421
      (Address of principal executive office) (Zip code)
(336) 664-1233
Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0001 par value QRVO The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filerþ Accelerated filer
Non-accelerated filer Smaller reporting company
 
 Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No þ

As of October 23, 2019,26, 2020, there were 116,174,131114,054,102 shares of the registrant’s common stock outstanding.
     

QORVO, INC. AND SUBSIDIARIES
INDEX
 
 Page    
 
  
 
  
  
  
  

PART I — FINANCIAL INFORMATION
ITEM 1.
QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)
 
September 28, 2019 March 30, 2019October 3, 2020 March 28, 2020
ASSETS      
Current assets:      
Cash and cash equivalents$586,794
 $711,035
$2,000,257
 $714,939
Accounts receivable, less allowance of $43 and $40 as of September 28, 2019 and March 30, 2019, respectively405,108
 378,172
Inventories (Note 3)
485,284
 511,793
Accounts receivable, net of allowance of $1,062 and $55 as of October 3, 2020 and March 28, 2020, respectively485,100
 367,172
Inventories476,846
 517,198
Prepaid expenses27,286
 25,766
42,178
 37,872
Other receivables14,137
 21,934
13,831
 15,016
Other current assets33,205
 36,141
44,514
 38,305
Total current assets1,551,814
 1,684,841
3,062,726
 1,690,502
Property and equipment, net of accumulated depreciation of $1,322,103 at September 28, 2019 and $1,218,507 at March 30, 20191,296,103
 1,366,513
Goodwill (Note 4)
2,305,136
 2,173,889
Intangible assets, net (Note 4)
451,788
 408,210
Long-term investments (Note 5)
97,549
 97,786
Other non-current assets (Note 6)
146,181
 76,785
Property and equipment, net of accumulated depreciation of $1,477,921 and $1,415,397 as of October 3, 2020 and March 28, 2020, respectively1,224,853
 1,259,203
Goodwill2,639,943
 2,614,274
Intangible assets, net714,565
 808,892
Long-term investments37,848
 22,515
Other non-current assets144,487
 165,296
Total assets$5,848,571
 $5,808,024
$7,824,422
 $6,560,682
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable$213,936
 $233,307
$242,147
 $246,954
Accrued liabilities172,345
 160,516
240,839
 217,801
Current portion of long-term debt (Note 7)
4,233
 80
Other current liabilities (Note 6)
59,115
 41,711
Current portion of long-term debt905,086
 6,893
Other current liabilities88,945
 67,355
Total current liabilities449,629
 435,614
1,477,017
 539,003
Long-term debt (Note 7)
1,016,063
 920,935
Other long-term liabilities (Note 6)
117,385
 91,796
Long-term debt1,764,396
 1,567,231
Other long-term liabilities175,843
 161,783
Total liabilities1,583,077
 1,448,345
3,417,256
 2,268,017
Commitments and contingent liabilities (Note 9)
   
Stockholders’ equity:      
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding
 
0
 0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 116,294 and 119,063 shares issued and outstanding at September 28, 2019 and March 30, 2019, respectively4,471,656
 4,687,455
Accumulated other comprehensive loss, net of tax(7,658) (6,624)
Accumulated deficit(198,504) (321,152)
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 114,111 and 114,625 shares issued and outstanding at October 3, 2020 and March 28, 2020, respectively4,267,987
 4,290,377
Accumulated other comprehensive income, net of tax26,616
 2,288
Retained earnings112,563
 0
Total stockholders’ equity4,265,494
 4,359,679
4,407,166
 4,292,665
Total liabilities and stockholders’ equity$5,848,571
 $5,808,024
$7,824,422
 $6,560,682
See accompanying Notes to Condensed Consolidated Financial Statements.

 QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended Six Months EndedThree Months Ended Six Months Ended
September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018October 3, 2020 September 28, 2019 October 3, 2020 September 28, 2019
Revenue$806,698
 $884,443
 $1,582,296
 $1,577,113
$1,060,292
 $806,698
 $1,847,743
 $1,582,296
Cost of goods sold483,116
 530,929
 964,425
 986,866
568,742
 483,116
 1,030,404
 964,425
Gross profit323,582
 353,514
 617,871
 590,247
491,550
 323,582
 817,339
 617,871
Operating expenses:              
Research and development115,614
 116,748
 234,534
 227,651
156,342
 115,614
 286,413
 234,534
Selling, general and administrative88,274
 139,507
 177,253
 275,437
109,372
 88,274
 195,976
 177,253
Other operating expense (Notes 4 and 10)
6,927
 6,782
 38,091
 15,897
Other operating expense4,192
 6,927
 20,594
 38,091
Total operating expenses210,815
 263,037
 449,878
 518,985
269,906
 210,815
 502,983
 449,878
Income from operations112,767
 90,477
 167,993
 71,262
Interest expense (Note 7)
(12,693) (9,689) (24,557) (24,042)
Operating income221,644
 112,767
 314,356
 167,993
Interest expense(23,486) (12,693) (42,335) (24,557)
Interest income2,292
 1,580
 5,238
 4,974
1,272
 2,292
 2,462
 5,238
Other expense (Note 7)
(300) (49,532) (1,411) (81,487)
Other income (expense), net648
 (300) 22,595
 (1,411)
              
Income (loss) before income taxes102,066
 32,836
 147,263
 (29,293)
Income before income taxes200,078
 102,066
 297,078
 147,263
              
Income tax (expense) benefit (Note 12)
(19,028) (752) (24,684) 31,384
Income tax expense(63,161) (19,028) (63,239) (24,684)
Net income$83,038
 $32,084
 $122,579
 $2,091
$136,917
 $83,038
 $233,839
 $122,579
              
Net income per share (Note 13):
       
Net income per share:       
Basic$0.71
 $0.26
 $1.04
 $0.02
$1.20
 $0.71
 $2.04
 $1.04
Diluted$0.70
 $0.25
 $1.02
 $0.02
$1.18
 $0.70
 $2.01
 $1.02
              
Weighted average shares of common stock outstanding (Note 13):
       
Weighted average shares of common stock outstanding:       
Basic117,294
 125,643
 117,945
 125,859
114,328
 117,294
 114,388
 117,945
Diluted119,429
 128,550
 120,196
 128,977
116,177
 119,429
 116,395
 120,196

See accompanying Notes to Condensed Consolidated Financial Statements.


QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited)
Three Months Ended Six Months EndedThree Months Ended Six Months Ended
September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018October 3, 2020 September 28, 2019 October 3, 2020 September 28, 2019
Net income$83,038
 $32,084
 $122,579
 $2,091
$136,917
 $83,038
 $233,839
 $122,579
Other comprehensive loss:       
Unrealized gain on marketable securities, net of tax
 85
 
 90
Other comprehensive income (loss):       
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term investment nature(1,242) (181) (1,455) (2,394)18,201
 (1,242) 24,288
 (1,455)
Reclassification adjustments, net of tax:              
Foreign currency loss included in net income231
 
 353
 
0
 231
 0
 353
Amortization of pension actuarial loss34
 24
 68
 48
21
 34
 40
 68
Other comprehensive loss(977) (72) (1,034) (2,256)
Total comprehensive income (loss)$82,061
 $32,012
 $121,545
 $(165)
Other comprehensive income (loss)18,222
 (977) 24,328
 (1,034)
Total comprehensive income$155,139
 $82,061
 $258,167
 $121,545
See accompanying Notes to Condensed Consolidated Financial Statements.



QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In thousands)
(Unaudited)



    Accumulated Other Comprehensive Loss Accumulated Deficit      Accumulated Other Comprehensive Income (Loss) Retained Earnings (Accumulated Deficit)  
Common Stock  Common Stock  
Three Months EndedShares Amount Total
Shares Amount Accumulated Other Comprehensive Income (Loss) Retained Earnings (Accumulated Deficit) Total
Balance, June 27, 2020114,354
 $4,293,621
 $4,351,245
Net income0
 0
 136,917
Other comprehensive income0
 0
 18,222
 0
 18,222
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes594
 (26,306) 0
 0
 (26,306)
Repurchase of common stock, including transaction costs(837) (31,425) 0
 (73,584) (105,009)
Stock-based compensation
 32,097
 0
 0
 32,097
Balance, October 3, 2020114,111
 $4,267,987
 $26,616
 $112,563
 $4,407,166
         
Balance, June 29, 2019117,943
 $4,625,566
 $(6,681) $(281,542) $4,337,343
117,943
 $4,625,566
 $(6,681) $(281,542) $4,337,343
Net income
 
 
 83,038
 83,038
0
 0
 0
 83,038
 83,038
Other comprehensive loss
 
 (977) 
 (977)0
 0
 (977) 0
 (977)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes652
 (12,033) 
 
 (12,033)652
 (12,033) 0
 0
 (12,033)
Repurchase of common stock, including transaction costs(2,301) (165,032) 
 
 (165,032)(2,301) (165,032) 0
 0
 (165,032)
Stock-based compensation
 23,155
 
 
 23,155

 23,155
 0
 0
 23,155
Balance, September 28, 2019116,294
 $4,471,656
 $(7,658) $(198,504) $4,265,494
116,294
 $4,471,656
 $(7,658) $(198,504) $4,265,494
         
Balance, June 30, 2018125,598
 $5,167,311
 $(4,936) $(484,270) $4,678,105
Net income
 
 
 32,084
 32,084
Other comprehensive loss
 
 (72) 
 (72)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes552
 (15,284) 
 
 (15,284)
Repurchase of common stock, including transaction costs(1,104) (86,678) 
 
 (86,678)
Stock-based compensation
 23,982
 
 
 23,982
Balance, September 29, 2018125,046
 $5,089,331
 $(5,008) $(452,186) $4,632,137




See accompanying Notes to Condensed Consolidated Financial Statements.


QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In thousands)
(Unaudited)



    Accumulated Other Comprehensive Loss Accumulated Deficit      Accumulated Other Comprehensive Income (Loss) Retained Earnings (Accumulated Deficit)  
Common Stock  Common Stock  
Six Months EndedShares Amount Total
Shares Amount Accumulated Other Comprehensive Income (Loss) Retained Earnings (Accumulated Deficit) Total
Balance, March 28, 2020114,625
 $4,290,377
 $4,292,665
Net income0
 0
 233,839
Other comprehensive income0
 0
 24,328
 0
 24,328
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes826
 (32,371) 0
 0
 (32,371)
Issuance of common stock in connection with employee stock purchase plan229
 15,758
 0
 0
 15,758
Cumulative-effect adoption of ASU 2016-130
 0
 0
 (38) (38)
Repurchase of common stock, including transaction costs(1,569) (58,830) 0
 (121,218) (180,048)
Stock-based compensation
 53,053
 0
 0
 53,053
Other0
 0
 0
 (20) (20)
Balance, October 3, 2020114,111
 $4,267,987
 $26,616
 $112,563
 $4,407,166
         
Balance, March 30, 2019119,063
 $4,687,455
 $(6,624) $(321,152) $4,359,679
119,063
 $4,687,455
 $(6,624) $(321,152) $4,359,679
Net income
 
 
 122,579
 122,579
0
 0
 0
 122,579
 122,579
Other comprehensive loss
 
 (1,034) 
 (1,034)0
 0
 (1,034) 0
 (1,034)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes837
 (15,609) 
 
 (15,609)837
 (15,609) 0
 0
 (15,609)
Issuance of common stock in connection with employee stock purchase plan239
 14,948
 
 
 14,948
239
 14,948
 0
 0
 14,948
Cumulative-effect adoption of ASU 2016-02
 
 
 69
 69
0
 0
 0
 69
 69
Repurchase of common stock, including transaction costs(3,845) (265,105) 
 
 (265,105)(3,845) (265,105) 0
 0
 (265,105)
Stock-based compensation
 49,967
 
 
 49,967

 49,967
 0
 0
 49,967
Balance, September 28, 2019116,294
 $4,471,656
 $(7,658) $(198,504) $4,265,494
116,294
 $4,471,656
 $(7,658) $(198,504) $4,265,494
         
Balance, March 31, 2018126,322
 $5,237,085
 $(2,752) $(458,769) $4,775,564
Net income
 
 
 2,091
 2,091
Other comprehensive loss
 
 (2,256) 
 (2,256)
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes818
 (19,859) 
 
 (19,859)
Issuance of common stock in connection with employee stock purchase plan249
 14,282
 
 
 14,282
Cumulative-effect adoption of ASU 2014-09


 
 
 4,492
 4,492
Repurchase of common stock, including transaction costs(2,343) (186,682) 
 
 (186,682)
Stock-based compensation
 44,505
 
 
 44,505
Balance, September 29, 2018125,046
 $5,089,331
 $(5,008) $(452,186) $4,632,137

See accompanying Notes to Condensed Consolidated Financial Statements.




QORVO, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

 Six Months Ended

September 28, 2019 September 29, 2018
Cash flows from operating activities:   
Net income$122,579
 $2,091
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation118,622
 90,214
Intangible assets amortization (Note 4)
114,837
 266,708
Loss on debt extinguishment (Note 7)

 82,152
Deferred income taxes(9,517) (42,962)
Stock-based compensation expense45,829
 40,250
Other, net5,153
 (1,714)
Changes in operating assets and liabilities:   
Accounts receivable, net(20,990) (145,874)
Inventories41,874
 556
Prepaid expenses and other current and non-current assets8,380
 1,589
Accounts payable and accrued liabilities(4,201) 23,980
Income tax payable and receivable5,072
 (20,965)
Other liabilities2,892
 (6,229)
Net cash provided by operating activities430,530
 289,796
Investing activities:   
Purchase of property and equipment(88,338) (113,666)
Purchase of available-for-sale debt securities
 (132,729)
Purchase of a business, net of cash acquired (Note 4)
(299,673) 
Proceeds from sales and maturities of available-for-sale debt securities1,950
 133,132
Other investing activities(1,242) (19,492)
Net cash used in investing activities(387,303) (132,755)
Financing activities:   
Repurchase of debt (Note 7)

 (954,745)
Proceeds from borrowings (Note 7)
100,000
 
Proceeds from debt issuances (Note 7)

 631,300
Repurchase of common stock, including transaction costs (Note 8)
(265,105) (186,682)
Proceeds from the issuance of common stock20,205
 18,406
Tax withholding paid on behalf of employees for restricted stock units(20,545) (24,181)
Other financing activities(832) (7,057)
Net cash used in financing activities(166,277) (522,959)
    
Effect of exchange rate changes on cash(1,091) (2,216)
Net decrease in cash, cash equivalents and restricted cash(124,141) (368,134)
Cash, cash equivalents and restricted cash at the beginning of the period711,382
 926,402
Cash, cash equivalents and restricted cash at the end of the period$587,241
 $558,268
Non-cash investing information:   
Capital expenditure adjustments included in accounts payable and accrued liabilities$30,052
 $44,634
    
Reconciliation of cash, cash equivalents and restricted cash   
Cash and cash equivalents$586,794
 $557,924
Restricted cash included in "Other non-current assets"447
 344
Total cash, cash equivalents and restricted cash587,241
 558,268
 Six Months Ended

October 3, 2020 September 28, 2019
Cash flows from operating activities:   
Net income$233,839
 $122,579
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation100,799
 118,622
Intangible assets amortization144,470
 114,837
Deferred income taxes36,468
 (9,517)
Stock-based compensation expense51,907
 45,829
Other, net(7,496) 12,036
Changes in operating assets and liabilities:   
Accounts receivable, net(118,008) (20,990)
Inventories41,844
 41,874
Prepaid expenses and other assets(2,366) 8,380
Accounts payable and accrued liabilities16,230
 (4,201)
Income taxes payable and receivable9,671
 5,072
Other liabilities(12,109) (3,991)
Net cash provided by operating activities495,249
 430,530
Cash flows from investing activities:   
Purchase of property and equipment(73,386) (88,338)
Purchase of businesses, net of cash acquired(47,520) (299,673)
Proceeds from sales of available-for-sale debt securities0
 1,950
Other investing activities9,581
 (1,242)
Net cash used in investing activities(111,325) (387,303)
Cash flows from financing activities:   
Payment of debt(100,000) 0
Proceeds from borrowings and debt issuances1,206,750
 100,000
Repurchase of common stock, including transaction costs(180,048) (265,105)
Proceeds from the issuance of common stock21,792
 20,205
Tax withholding paid on behalf of employees for restricted stock units(36,354) (20,545)
Other financing activities(11,705) (832)
Net cash provided by (used in) financing activities900,435
 (166,277)
    
Effect of exchange rate changes on cash, cash equivalents and restricted cash936
 (1,091)
Net increase (decrease) in cash, cash equivalents and restricted cash1,285,295
 (124,141)
Cash, cash equivalents and restricted cash at the beginning of the period715,612
 711,382
Cash, cash equivalents and restricted cash at the end of the period$2,000,907
 $587,241
    
Non-cash investing information:   
Capital expenditure adjustments included in liabilities$22,124
 $30,052
    
Reconciliation of cash, cash equivalents and restricted cash:   
Cash and cash equivalents$2,000,257
 $586,794
Restricted cash included in "Other current assets" and "Other non-current assets"650
 447
Total cash, cash equivalents and restricted cash$2,000,907
 $587,241

See accompanying Notes to Condensed Consolidated Financial Statements.

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

The accompanying Condensed Consolidated Financial Statements of Qorvo, Inc. and Subsidiaries (together, the "Company"“Company” or "Qorvo"“Qorvo”) have been prepared in conformity with accounting principles generally accepted in the United States ("(“U.S. GAAP"GAAP”). The preparation of these financial statements requires management to make estimates and assumptions, which could differ materially from actual results. In addition, certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed, or omitted, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, the financial statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. These Condensed Consolidated Financial Statements should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended March 30, 201928, 2020.

The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal 20192020 financial statements have been reclassified to conform with the fiscal 20202021 presentation.

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The first fiscal quarter of each year ends on the Saturday closest to June 30, the second fiscal quarter of each year ends on the Saturday closest to September 30 and the third fiscal quarter of each year ends on the Saturday closest to December 31. Fiscal years2021 is a 53-week fiscal year during which the second fiscal quarter ended October 3, 2020 and 2019 are 52-week years.included 14 weeks, compared to 13 weeks for the second fiscal quarter ended September 28, 2019. The first six months of fiscal 2021 ended October 3, 2020 and included 27 weeks, compared to 26 weeks for the six months ended September 28, 2019.

2. RECENT ACCOUNTING PRONOUNCEMENTS

The Company assesses recently issued accounting standards by the Financial Accounting Standards Board ("FASB") to determine the expected impacts on the Company's financial statements. The summary below describes impacts from newly issued standards as well as material updates to our previous assessments, if any, from Qorvo’s Annual Report on Form 10-K for the fiscal year ended March 30, 2019.28, 2020.

In FebruaryJune 2016, the FASB issued Accounting Standards Update 2016-02, ("ASU") 2016-13, ""LeasesFinancial Instruments-Credit Losses (Topic 842)326): Measurement of Credit Losses on Financial Instruments," with multiple amendments subsequently issued. The new guidance which requires that lease arrangementsa current lifetime expected credit loss methodology to be presented onused to measure impairments of accounts receivable and other financial assets. Using this methodology will result in earlier recognition of losses than under the lessee's balance sheet by recordingprevious incurred loss approach, which requires waiting to recognize a right-of-use asset and a lease liability equal to the present valueloss until it is probable of the related future minimum lease payments.being incurred. The Company adopted the standard, which applies to its accounts receivables, in the first quarter of fiscal 2020,2021.

Under this new standard, trade receivables are now evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics. These aggregated risk pools will be reassessed at each measurement date. A combination of factors is considered in determining the appropriate estimate of expected credit losses which include broad-based economic indicators as well as customers' financial strength, credit standing, payment history and any historical defaults.

The adoption of this standard using the modified retrospective approach which permits lessees to recognize a cumulative-effect adjustment to the opening balance of accumulated deficit in the period of adoption. Upon adoption, the Company recorded a right-of-use asset of $70.7 million and a lease liability of $75.0 million.  The difference between the right-of-use asset and lease liability is primarily attributed to a deferred rent liability which existed under Accounting Standards Codification ("ASC") 840, "Leases.

The Company elected the transition package of practical expedients, under which the Company does not have to reassess (1) whether any expired or existing contracts are leases, or contain leases, (2) the lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases. Further, the Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet.

The adoption of this standardmethod resulted in a cumulative-effect adjustment to accumulated deficitretained earnings of less than $0.1 million. This standard did not have a material impact on the Condensed Consolidated Statement of Income or Condensed Consolidated Statement of Cash Flows. See Note 6 for further disclosures resulting from the adoption of this new standard.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


3. INVENTORIES
The components of inventories, net of reserves, are as follows (in thousands):
September 28, 2019 March 30, 2019October 3, 2020 March 28, 2020
Raw materials$106,500
 $118,608
$114,391
 $112,671
Work in process259,031
 272,469
233,826
 291,028
Finished goods119,753
 120,716
128,629
 113,499
Total inventories$485,284
 $511,793
$476,846
 $517,198


4. BUSINESS ACQUISITIONACQUISITIONS

On May 6, 2019,During the three months ended October 3, 2020, the Company completed itsthe acquisition of 7Hugs Labs S.A.S. ("7Hugs"). During fiscal 2020, the Company completed the acquisitions of Decawave Limited ("Decawave"), Custom MMIC Design Services, Inc. ("Custom MMIC"), Cavendish Kinetics Limited ("Cavendish") and Active-Semi International, Inc. ("Active-Semi"),. The operating results of these companies have been included in the Company's consolidated financial statements as of the acquisition dates.

7Hugs Labs S.A.S.

On October 1, 2020, the Company acquired all of the outstanding equity interests of 7Hugs, a private fabless supplierdeveloper of programmable analog power solutions.ultra-wide band ("UWB") software and solutions, for a total purchase price of $48.7 million, including cash acquired of $1.0 million. The acquisition expandedexpands the Company's product offerings for existing customers and new customers in power management markets. is expected to support the ongoing development and adoption of UWB products and solutions.

The purchase price of $309.5 million was allocated to Active-Semi's7Hugs' net tangible assetsliabilities (approximately $19.8$5.4 million, which includes debt assumed), deferred tax liability (approximately $1.7 million) and an intangible assetsasset (approximately $158.4 million)$37.3 million, entirely related to developed technology) based on their estimated fair values as of May 6, 2019. October 1, 2020. The fair value of the developed technology was determined based on an income approach using the "relief from royalty method," which estimated the value by discounting the royalties avoided by acquiring the technology to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over the estimated useful life of 10 years.

The excess of the purchase price over the value of the net tangible assetsliabilities, deferred tax liability and intangible assetsasset resulted in goodwill of approximately $131.2$18.5 million. The more significant intangible assets acquired included developed technology of $76.7 million (being amortized over 5 to 9 years), customer relationships of $40.9 million (being amortized over 5 years) and in-process research and development ("IPRD") of $40.6 million. During the six months ended September 28, 2019, $31.0 million of IPRD assets were completed, transferred to finite-lived intangible assets, and are being amortized over their useful lives of 5 to 7 years. The IPRD remaining as of September 28, 2019 is expected to be completed during fiscal 2021 with remaining costs to complete of less than $2.0 million.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). During the three months ended October 3, 2020, the Company recorded acquisition and integration costs associated with the acquisition of 7Hugs of $1.4 million in "Other operating expense" in the Condensed Consolidated Statement of Income.

Decawave Limited

On February 21, 2020, the Company acquired all of the outstanding equity interests of Decawave, a pioneer in UWB technology and provider of UWB solutions for mobile, automotive and Internet of Things ("IoT") applications, for a total purchase price of $372.7 million. The acquisition expands the Company's product and technology offerings that are subjectenables real-time, highly accurate and reliable local area precision-location services.

During the six months ended October 3, 2020, the Company recognized a decrease to change withingoodwill of approximately $2.6 million as a result of purchase price allocation adjustments. The Company will continue to evaluate certain assets, liabilities, and tax estimates over the measurement period (up to one year from the acquisition date).

Custom MMIC Design Services, Inc.

On February 6, 2020, the Company acquired all of the outstanding equity interests of Custom MMIC, a supplier of high-performance gallium arsenide ("GaAs") and gallium nitride ("GaN") monolithic microwave integrated circuits ("MMICs") for defense and commercial applications, for a total purchase price of $91.7 million. The Company recorded postcombination compensation expenseacquisition expands the Company's

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

millimeter wave ("mmWave") capabilities for product offerings in defense and commercial markets. On the acquisition date, the purchase price was comprised of cash consideration of $86.0 million and contingent consideration of $5.7 million (based on estimated fair value) which is payable to the sellers in the first quarter of fiscal 2022 if certain revenue targets are achieved over a one-year period from the acquisition date. The contingent consideration liability is remeasured to fair value each period with changes recognized in "Other operating expense." The fair value of the contingent consideration liability as well as other acquisition and integrationof October 3, 2020 was equal to the maximum amount payable of $10.0 million, which is included in "Accrued liabilities." See Note 6 for further information related costs duringto the three andfair value measurement.

During the six months ended October 3, 2020, the Company recognized a decrease to goodwill of approximately $0.6 million as a result of purchase price allocation adjustments. The Company will continue to evaluate certain assets, liabilities, and tax estimates over the measurement period (up to one year from the acquisition date).

Cavendish Kinetics Limited

As of September 28, 2019, the Company had an investment in preferred shares in Cavendish, a private supplier of $1.7high-performance radio frequency ("RF") microelectromechanical system ("MEMS") technology for antenna tuning applications, with a carrying value of $59.4 million. The Company accounted for this investment as an equity investment without a readily determinable fair value using the measurement alternative in accordance with ASC 321, "Investments-Equity Securities."

On October 4, 2019, the Company acquired the remaining issued and outstanding capital of Cavendish for cash consideration of $198.4 million. The acquisition advances RF MEMS technology for applications across the Company's products and the technology will be transitioned into high-volume manufacturing for mobile devices and other markets.

The purchase of the remaining equity interest in Cavendish was considered to be an acquisition achieved in stages, whereby the previously held equity interest was remeasured at its acquisition-date fair value. The Company determined that the fair value of its previously held equity investment was $102.4 million based on the purchase consideration exchanged to acquire the remaining issued and $23.0outstanding capital of Cavendish, which resulted in recognition of a gain of $43.0 million respectively, in "Other operating expense" in the Condensed Consolidated Statementsthird quarter of Income. In addition,fiscal 2020.

During the Company recorded acquisition and integration related costs during the three and six months ended September 28, 2019October 3, 2020, the Company recognized an increase to goodwill of $3.5approximately $1.6 million and $4.2a decrease to intangibles of approximately $2.0 million respectively,as a result of purchase price allocation adjustments. The measurement period ended one year from the acquisition date of October 4, 2019.

Active-Semi International, Inc.

On May 6, 2019, the Company acquired all of the outstanding equity interests of Active-Semi, a private fabless supplier of programmable analog power management solutions, for a total purchase price of $307.9 million. The acquisition expanded the Company's product offerings in "Costpower management markets.

During the six months ended October 3, 2020, the Company recognized an increase to goodwill of goods sold"approximately $0.1 million in connection with finalizing the Condensed Consolidated Statements of Income.purchase price allocation. The measurement period ended one year from the acquisition date.

5. GOODWILL AND INTANGIBLE ASSETS

The changechanges in the carrying amount of goodwill for the six months ended September 28, 2019, isOctober 3, 2020 are as follows (in thousands):
 Mobile Products Infrastructure and Defense Products Total
Balance as of March 30, 2019$1,751,503
 $422,386
 $2,173,889
Goodwill resulting from Active-Semi acquisition
 131,247
 131,247
Balance as of September 28, 2019$1,751,503
 $553,633
 $2,305,136
 Mobile Products Infrastructure and Defense Products Total
Balance as of March 28, 2020 (1)
$2,005,432
 $608,842
 $2,614,274
Goodwill resulting from 7Hugs acquisition (Note 4)
18,527
 
 18,527
Measurement period adjustments (Note 4)
(951) (508) (1,459)
Foreign currency translation8,601
 0
 8,601
Balance as of October 3, 2020 (1)
$2,031,609
 $608,334
 $2,639,943
(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

Goodwill is allocated to the reporting units that are expected to benefit from the synergies of the business combinations generating the underlying goodwill.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):
September 28, 2019 March 30, 2019October 3, 2020 March 28, 2020
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Intangible assets:       
Developed technology$871,872
 $557,626
 $1,246,335
 $960,793
$1,269,772
 $665,442
 $1,325,472
 $652,400
Customer relationships426,522
 309,864
 1,272,725
 1,161,735
458,150
 380,121
 463,772
 346,799
Technology licenses2,271
 1,706
 3,271
 2,327
Backlog1,600
 1,067
 1,600
 267
Trade names
200
 167
 29,391
 29,391
1,000
 333
 1,200
 283
Technology licenses3,205
 1,954
 14,704
 13,026
Non-compete agreement
 
 1,026
 1,026
IPRD19,600
 N/A
 10,000
 N/A
In-process research and development9,600
 N/A
 9,600
 N/A
Foreign currency translation21,802
 961
 6,064
 11
Total$1,321,399
 $869,611
 $2,574,181
 $2,165,971
$1,764,195
 $1,049,630
 $1,810,979
 $1,002,087

InAt the first quarterbeginning of each fiscal year, the Company removes the fully amortized balances from the gross asset and accumulated amortization amounts of those intangible assets that werehave reached the end of their useful lives and have been fully amortized as ofamortized. Useful lives are estimated based on expected economic benefit to be derived from the prior fiscal year end.intangible assets.

Total intangible assets amortization expense was $72.4 million and $144.5 million for the three and six months ended October 3, 2020, respectively, and $56.4 million and $114.8 million respectively, for the three and six months ended September 28, 2019, and $133.4 million and $266.7 million, respectively, for the three and six months ended September 29, 2018.respectively.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


56. INVESTMENTS AND FAIR VALUE MEASUREMENTSOF FINANCIAL INSTRUMENTS

RecurringEquity Method Investments
The Company invests in limited partnerships which are accounted for using the equity method. The carrying amounts of these investments as of October 3, 2020 and March 28, 2020 were $29.8 million and $14.2 million, respectively, and are classified as “Long-term investments” in the Condensed Consolidated Balance Sheets. During the three and six months ended October 3, 2020, the Company recorded $0.1 million of expense and $15.6 million of income, respectively, based on its share of the limited partnerships' earnings. These amounts are included in “Other income (expense), net” in the Condensed Consolidated Statements of Income.

Equity Investments Without a Readily Determinable Fair Value Measurements
During the fourth quarter of fiscal 2020, the Company recorded an impairment of $18.3 million on an equity investment without a readily determinable fair value based on observable price changes present at the time. During the first quarter of fiscal 2021, the Company recorded an additional impairment of $2.8 million to fully impair this investment. This amount is recorded in “Other income (expense), net” in the Condensed Consolidated Statement of Income.

Fair Value of Financial Instruments
The fair value of the financial assets and liabilities measured at fair value on a recurring basis was determined using the following levels of inputs as of September 28, 2019October 3, 2020 and March 30, 201928, 2020 (in thousands):
     Total Quoted Prices In
Active Markets For
Identical Assets
(Level 1)
 Significant Other
Observable Inputs
(Level 2)
September 28, 2019     
 Assets     
  Marketable equity securities$979
 $979
 $
  
Invested funds in deferred compensation plan (1)

20,541
 20,541
 
    Total assets measured at fair value$21,520
 $21,520
 $
 Liabilities     
  
Deferred compensation plan obligation (1)
$20,541
 $20,541
 $
    Total liabilities measured at fair value$20,541
 $20,541
 $
          
March 30, 2019     
 Assets     
  Money market funds$13
 $13
 $
  Marketable equity securities901
 901
 
  
Auction rate securities (2)

1,950
 
 1,950
  
Invested funds in deferred compensation plan (1)

18,737
 18,737
 
    Total assets measured at fair value$21,601
 $19,651
 $1,950
 Liabilities     
  
Deferred compensation plan obligation (1)
$18,737
 $18,737
 $
    Total liabilities measured at fair value$18,737
 $18,737
 $
     Total 
Quoted Prices In
Active Markets For
Identical Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
October 3, 2020       
 Assets       
  Marketable equity securities$282
 $282
 $0
 $0
  
Invested funds in deferred compensation plan (1)
26,316
 26,316
 0
 0
    Total assets measured at fair value$26,598
 $26,598
 $0
 $0
 Liabilities       
  
Deferred compensation plan obligation (1)
$26,316
 $26,316
 $0
 $0
  
Contingent earn-out liability (2)
10,000
 0
 0
 10,000
    Total liabilities measured at fair value$36,316
 $26,316
 $0
 $10,000
            
March 28, 2020       
 Assets       
  Marketable equity securities$459
 $459
 $0
 $0
  
Invested funds in deferred compensation plan (1)
19,398
 19,398
 0
 0
    Total assets measured at fair value$19,857
 $19,857
 $0
 $0
 Liabilities       
  
Deferred compensation plan obligation (1)
$19,398
 $19,398
 $0
 $0
  
Contingent earn-out liability (2)
5,700
 0
 0
 5,700
    Total liabilities measured at fair value$25,098
 $19,398
 $0
 $5,700
(1) The Company's non-qualified deferred compensation plan provides eligible employees and members of the Board of Directors with the opportunity to defer a specified percentage of their cash compensation. The Company includes the assets deferred by the participants in the “Other current assets” and “Other non-current assets” line items of its Condensed Consolidated Balance Sheets and the Company's obligation to deliver the deferred compensation in the "Other“Other current liabilities"liabilities” and “Other long-term liabilities” line items of its Condensed Consolidated Balance Sheets.
(2) The Company's Level 2 auction rate securities were debt instrumentsCompany recorded a contingent earn-out liability in conjunction with interest rates that reset through periodic short-term auctions and were valued based on quoted prices for identical or similar instruments in markets that were not active. During the first quarter of fiscal 2020, the Company sold its auction rate securities at par value.
As of September 28, 2019 and March 30, 2019, the Company did not have any Level 3 assets or liabilities.

Equity Investment Without a Readily Determinable Fair Value
As of September 28, 2019, the Company has invested $60.0 million to acquire preferred shares of Cavendish Kinetics Limited (“Cavendish”). This investment was determined to be an equity investment without a readily determinableCustom MMIC acquisition. The fair value of this liability is estimated using an option pricing model and is accounted for using the measurement alternativeremeasured to fair value each period with changes in accordance with ASC 321, "Investments - Equity Securities." As of September 28, 2019, there was no impairment or observable price change for this investment. This investment is classifiedfair value reported in "Long-term investments" in the Condensed Consolidated Balance Sheets. See Note 15 for additional disclosures related to the subsequent acquisition of the entire issued and outstanding capital of Cavendish.

“Other operating

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


Fair Value of Financial Instruments
Marketable securities are measured at fair value and recorded in "Cash and cash equivalents," "Other current assets" and "Long-term investments" in the Condensed Consolidated Balance Sheets, and the related unrealized gains and losses are included in "Accumulated other comprehensive loss," a component of stockholders’ equity, net of tax (debt securities) and "Other income (expense)"expense” in the Condensed Consolidated Statements of Income (equity securities).

Other Fair Value Disclosures
The carrying values Income. As of cash and cash equivalents, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. See Note 7 for further disclosures related toOctober 3, 2020, the fair value of the Company's debt.contingent consideration liability was equal to the maximum amount payable of $10.0 million. NaN payments have been made for the contingent liability as the earn-out assessment period is still ongoing. Any anticipated payments are expected to be settled during the first quarter of fiscal 2022.

7. LONG-TERM DEBT

Long-term debt as of October 3, 2020 and March 28, 2020 is as follows (in thousands):
 October 3, 2020 March 28, 2020
Term loan$200,000
 $100,000
7.00% senior notes due 202523,404
 23,404
5.50% senior notes due 2026 (1)
900,000
 900,000
4.375% senior notes due 2029850,000
 550,000
3.375% senior notes due 2031700,000
 0
Finance leases1,606
 2,252
Unamortized premium and issuance costs, net(5,528) (1,532)
Less current portion of long-term debt (1)
(905,086) (6,893)
Total long-term debt$1,764,396
 $1,567,231
6. LEASES
The(1) On October 16, 2020, the Company leases certaincompleted the redemption of all of its corporate, manufacturing and other facilities from multiple third-party real estate developers. The Company also leases various machinery and office equipment. These operating leases expire at various dates through 2036, and someoutstanding 5.50% senior notes due 2026. As of these leases have renewal options, withOctober 3, 2020, the longest ranging up to two, ten-year periods.

In fiscal 2018, the Company entered into a finance lease whichoutstanding principal balance is expected to commenceincluded in fiscal 2021 and is not recorded"Current portion of long-term debt" in the Condensed Consolidated Balance Sheet as of September 28, 2019. The Company’s other finance lease, which is classified in "Property(see below and equipment" in the Condensed Consolidated Balance Sheets, is immaterialNote 15 for disclosure.additional information).

The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists,Credit Agreement
On September 29, 2020, the Company assesses whether it hasand certain of its U.S. subsidiaries (the “Guarantors”) entered into a five-year unsecured senior credit facility pursuant to a credit agreement (the "2020 Credit Agreement") with Bank of America, N.A. acting as administrative agent (the “Administrative Agent”) and a syndicate of lenders. The 2020 Credit Agreement amended and restated the rightprevious credit agreement dated as of December 5, 2017 (the “2017 Credit Agreement”). The 2020 Credit Agreement includes a senior term loan (the "2020 Term Loan") of up to direct$200.0 million and a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million (collectively the use“Credit Facility”).

On the closing date of the identified asset and obtain substantially all2020 Credit Agreement, the Company repaid the remaining principal balance of the economic benefit from the use of the identified asset.

Right-of-use assets and liabilities are recognized at the lease commencement date based$97.5 million on the present value of lease payments overterm loan under the lease term. The Company uses its estimated incremental borrowing rate in determining2017 Credit Agreement (the “2017 Term Loan”) and concurrently drew $200.0 million under the present value of lease payments considering2020 Term Loan. Interest paid on the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised, and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time.

The components of lease expense for operating leases for2017 Term Loan during the three and six months ended September 28, 2019, are as follows:
 September 28, 2019
 Three Months Ended Six Months Ended
Operating lease expense$3,963
 $7,417
Short-term lease expense1,187
 3,152
Variable lease expense1,181
 1,595
Total lease expense$6,331
 $12,164

October 3, 2020 was $0.4 million and $0.8 million, respectively.

Supplemental cash informationPursuant to the 2020 Credit Agreement, the Company may request one or more additional tranches of term loans or increases to the Revolving Facility, up to an aggregate of $500.0 million and non-cash activities relatedsubject to operating leasessecuring additional funding commitments from the existing or new lenders. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Credit Facility is available to finance working capital, capital expenditures and other general corporate purposes. Outstanding amounts are due in full on the maturity date of September 29, 2025, subject to scheduled amortization of the 2020 Term Loan principal prior to the maturity date as follows (in thousands): set forth in the 2020 Credit Agreement. During the six months ended October 3, 2020, there were 0 borrowings under the Revolving Facility.

 Six Months Ended
 September 28, 2019
Cash paid for amounts included in measurement of lease liabilities: 
Operating cash flows from operating leases$8,377
  
Non-cash activities: 
Operating lease assets obtained in exchange for new lease liabilities$2,486

At the Company’s option, loans under the 2020 Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the 2020 Credit Agreement) plus the Eurodollar Rate (as defined in the 2020 Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate as set by the Administrative Agent, and (c) the Eurodollar Rate plus 1.0% (the “Base Rate”). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Eurodollar Rate is the rate per annum equal to the reserve adjusted London Interbank Offered Rate (or a comparable or successor rate), for dollar deposits for interest periods of one, two, three or six months, as selected by the Company. The Applicable Rate for Eurodollar Rate loans ranges from 1.000% per annum to 1.250% per annum and is set at 1.125% per annum until the delivery of the Company’s first compliance certificate to the lenders following the fiscal quarter ending January 2, 2021. The Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.250% per annum, and is set at 0.125% per annum until the delivery of the Company’s first compliance certificate to the lenders following the fiscal

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


Supplemental balance sheet information relatedquarter ending January 2, 2021. Undrawn amounts under the Credit Facility are subject to operating leasesa commitment fee ranging from 0.150% to 0.200%. Interest for Eurodollar Rate loans is as follows (in thousands):
    Classification on the Condensed Consolidated Balance Sheet September 28, 2019
Assets     
Operating lease assets Other non-current assets $61,693
      
Liabilities     
Operating lease current liabilities  Other current liabilities $12,965
Operating lease non-current liabilities  Other long-term liabilities $56,923

Weighted-average remaining lease term and discount rate related to operating leases are as follows:
September 28, 2019
Weighted-average remaining lease term (years) - operating leases8.70
Weighted-average discount rate - operating leases4.24%

Maturitiespayable at the end of lease liabilities under operating leases by fiscal year as of September 28, 2019 are as follows (in thousands):
 September 28, 2019
2020$7,575
202114,980
202211,823
20239,167
20247,802
Thereafter32,011
Total lease payments83,358
Less imputed interest(13,470)
Present value of lease liabilities$69,888

each applicable interest period or at three-month intervals if such interest period exceeds three months. Interest for Base Rate loans is payable quarterly in arrears.

7. DEBT

Long-term debt asThe 2020 Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and to avoid an event of September 28, 2019 and March 30, 2019 is as follows (in thousands):
 September 28, 2019 March 30, 2019
Term loan$100,000
 $
7.00% senior notes due 202523,404
 23,404
5.50% senior notes due 2026900,000
 900,000
Finance leases2,123
 1,745
Less unamortized premium and issuance costs(5,231) (4,134)
Less current portion of long-term debt(4,233) (80)
Total long-term debt$1,016,063
 $920,935

default. As of October 3, 2020, the Company was in compliance with these covenants.

Senior Notes due 2023 and 2025
On November 19, 2015, the Company issued $450.0$550.0 million aggregate principal amount 6.75% senior notes due December 1, 2023 (the "2023 Notes") and $550.0 million aggregate principal amountof its 7.00% senior notes due December 1, 2025 (the "2025 Notes"“2025 Notes”). The 2023Interest on the 2025 Notes were,is payable on June 1 and theDecember 1 of each year. The 2025 Notes are senior unsecured obligations of the Company and guaranteed, jointly and severally, by the Company and certain of its U.S. subsidiaries (the "Guarantors").Guarantors. The 2023 Notes and the 2025 Notes were issued pursuant to an indenture dated as of November 19, 2015 (the "2015 Indenture"“2015 Indenture”), by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee. The 2015 Indenture contains customary events of default, including payment default, failure to provide certain notices and certain provisions related to bankruptcy events.

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)



In fiscal years 2018 and 2019, the Company retired all of the issued and outstanding 2023 Notes and $526.6 million of the 2025 Notes.  During the three and six months ended September 29, 2018, the Company recognized a loss on debt extinguishment of $48.8 million and $82.2 million, respectively, as "Other expense" in the Condensed Consolidated Statements of Income in connection with certain purchases of the 2023 Notes and the 2025 Notes. As of September 28, 2019,October 3, 2020, an aggregate principal amount of $23.4 million of the 2025 Notes remained outstanding.

With respect to the 2023 Notes, interest was payable on June 1 and December 1 of each year at a rate of 6.75% per annum, and with respect to the 2025 Notes, interest is payable on June 1 and December 1 of each year at a rate of 7.00% per annum. The Company paid 0 interest on the 2025 Notes during the three months ended October 3, 2020 and September 28, 2019, and paid interest of $0.8 million on the 2025 Notes during each of the six months ended October 3, 2020 and September 28, 2019. Interest paid on the 2023 Notes and the 2025 Notes during the three and six months ended September 29, 2018 was $7.3 million and $41.5 million, respectively.

Senior Notes due 2026
On July 16, 2018, the Company issued $500.0 million aggregate principal amount of its 5.50% senior notes due July 15, 2026 (the “Initial 2026 Notes”). On August 28, 2018 and March 5, 2019, the Company issued an additional $130.0 million and $270.0 million, respectively, aggregate principal amount of such notes (together, the "Additional“Additional 2026 Notes"Notes” and together with the Initial 2026 Notes, the "2026 Notes"“2026 Notes”). TheInterest is payable on the 2026 Notes will mature on January 15 and July 15 2026, unless earlier redeemed in accordance with their terms.of each year. The 2026 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by the Guarantors.

The Initial 2026 Notes were issued pursuant to an indenture, dated as of July 16, 2018, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2026 Notes were issued pursuant to supplemental indentures, dated as of August 28, 2018 and March 5, 2019 respectively (such indenture and supplemental indentures, collectively, the "2018 Indenture"“2018 Indenture”). The 2018 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

During the three and six months ended October 3, 2020 and September 28, 2019, interest paid on the 2026 Notes was $24.8 million.

During the three months ended October 3, 2020, in connection with the offering of the 2031 Notes (as defined below), the Company delivered to MUFG Union Bank, N.A., as trustee, a Notice of Redemption for all of the outstanding 2026 Notes, at a cash redemption price to be calculated as provided in the 2026 Notes, plus accrued and unpaid interest, to the redemption date of October 16, 2020.

On October 16, 2020, the Company completed the redemption of the 2026 Notes at a redemption price equal to 106.363% of the principal amount, plus accrued and unpaid interest. The 2026 Notes were redeemed using proceeds from the recent issuance of the 2031 Notes (as defined below) combined with cash on hand plus borrowings under the 2020 Term Loan.

The principal balance of the 2026 Notes was reclassified as of October 3, 2020 from "Long-term debt" to "Current portion of long-term debt" in the Condensed Consolidated Balance Sheet due to the Company's intention to retire the obligation soon after the balance sheet date.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

Senior Notes due 2029
On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the “Initial 2029 Notes”). On December 20, 2019 and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the “Additional 2029 Notes” and together with the Initial 2029 Notes, the “2029 Notes”). Interest is payable on the 2029 Notes on April 15 and October 15 of each year. The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019 and June 11, 2020 (such indenture and supplemental indentures, collectively, the “2019 Indenture”). The 2019 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

In connection with the offerings of the 20262029 Notes, the Company agreed to provide the holders of the 20262029 Notes with an opportunity to exchange the 20262029 Notes for registered notes having terms substantially identical to the 20262029 Notes. On June 25, 2019,August 28, 2020, the Company completed the exchange offer, in which substantially all of the privately placed 20262029 Notes were exchanged for new notes that have been registered under the Securities Act of 1933, as amended (the "Securities Act"“Securities Act”).

The Company paid 0 interest on the 2029 Notes during the three months ended October 3, 2020 and paid interest of $13.0 million on the 2029 Notes during the six months ended October 3, 2020.

Senior Notes due 2031
On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the “2031 Notes”). Interest is payable on the 20262031 Notes on January 15April 1 and July 15October 1 of each year, at a ratecommencing April 1, 2021. The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of 5.50% per annum. Interest paid on the 2026 Notes during the three and six months ended September 28, 2019 was $24.8 million.

Credit Agreement
On December 5, 2017, the Company and are initially guaranteed, jointly and severally, by the Guarantors entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent (in such capacity, the “Administrative Agent”), swing line lender and L/C issuer, and a syndicate of lenders (the "Credit Agreement"). The Credit Agreement includes a senior delayed draw term loan of up to $400.0 million (the "Term Loan") and a $300.0 million senior revolving line of credit (the "Revolving Facility", together with the Term Loan, the "Credit Facility"). On the closing date, $100.0 million of the Term Loan was funded (and subsequently repaid in March 2018). On June 17, 2019, the Company drew $100.0 million of the Term Loan, with the remaining $200.0 million available, at the discretion of the Company, in a final draw. Subsequent amendments to the Credit Agreement have, among other things, extended the delayed draw availability period to December 31, 2019. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Company may request that the Credit Facility be increased by up to $300.0 million, subject to securing additional funding commitments from the existing or new lenders. The Credit Facility is available to finance working capital, capital expenditures and other corporate purposes. Outstanding amounts are due in full on the maturity date of December 5, 2022 (with amounts borrowed under the swingline option due in full no later than ten business days after such loan is made), subject to scheduled amortization of the Term Loan principal as set forth in the Credit Agreement prior to the maturity date. During the six months ended September 28, 2019, there were 0 borrowings under the Revolving Facility. Interest paid on the Term Loan during the three and six months ended September 28, 2019 was $0.9 million.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

Guarantors.

The Credit Agreement contains various conditions, covenants2031 Notes were sold in a private offering to certain institutions that then resold the 2031 Notes in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act, and representationsto certain non-U.S. persons in accordance with whichRegulation S under the Securities Act. The Company used the net proceeds of the offering of the 2031 Notes, together with the 2020 Term Loan and cash on hand, to redeem all of the outstanding 2026 Notes as described above.

The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, mustthe Guarantors and MUFG Union Bank, N.A., as trustee (the “2020 Indenture”). The 2020 Indenture contains customary events of default, including payment default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

The 2031 Notes have not been and will not be registered under the Securities Act, or any state securities laws, and may not be offered or sold in compliance in order to borrow fundsthe United States absent an applicable exemption from the registration requirements of the Securities Act and to avoid an event of default. As of September 28, 2019, the Company was in compliance with these covenants.applicable state securities laws.

Fair Value of Debt
The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2025 Notes, 2026 Notes, 2029 Notes and the 20262031 Notes as of September 28, 2019October 3, 2020 was $25.1$23.7 million, $956.1 million, $906.3 million, and $954.8$713.1 million, respectively (compared to a carrying value of $23.4 million, $900.0 million, $850.0 million, and $900.0$700.0 million, respectively). The estimated fair value of the 2025 Notes, 2026 Notes and the 20262029 Notes as of March 30, 201928, 2020 was $25.8$23.9 million, $962.8 million, and $929.3$489.5 million, respectively.respectively (compared to a carrying value of $23.4 million, $900.0 million, and $550.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2025 Notes, 2026 Notes, 2029 Notes and 20262031 Notes trade over the counter, and their fair values were estimated based upon the value of their last trade at the end of the period.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

The Company had no outstanding amounts under the Revolving Facility as of September 28, 2019. The2020 Term Loan carries a variable interest rate set at current market rates, and as such, the fair value of the 2020 Term Loan approximated book value as of September 28, 2019.October 3, 2020.

Interest Expense
During the three and six months ended October 3, 2020, the Company recognized interest expense of $24.6 million and $44.6 million, respectively, primarily related to the 2026 Notes and the 2029 Notes, which was partially offset by interest capitalized to property and equipment of $1.1 million and $2.3 million, respectively. During the three and six months ended September 28, 2019, the Company recognized $13.6interest expense of $14.0 million and $26.5$27.6 million, respectively, of interest expenseprimarily related to the 2025 Notes, the 2026 Notes and the Term Loan, which was partially offset by $1.3 million and $3.0 million, respectively, of interest capitalized to property and equipment. During the three and six months ended September 29, 2018, the Company recognized $10.9 million and $28.0 million, respectively, of interest expense related to the 2023 Notes, the 2025 Notes and the 2026 Notes, which was partially offset by $1.8 million and $5.3 million, respectively, of interest capitalized to property and equipment.equipment of $1.3 million and $3.0 million, respectively.

8. STOCK REPURCHASES

On May 23, 2018,October 31, 2019, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $1.0 billion of the Company's outstanding common stock, which included approximately $126.3$117.0 million authorized under the prior program which was terminated concurrent with the new authorization. Under this program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice.

During the three and six months ended October 3, 2020, the Company repurchased approximately 0.8 million and 1.6 million shares, respectively, of its common stock for approximately $105.0 million and $180.0 million, respectively, under the current share repurchase program. As of October 3, 2020, approximately $585.9 million remained available for repurchases under the current share repurchase program.

During the three and six months ended September 28, 2019, the Company repurchased approximately 2.3 million shares and 3.8 million shares, respectively, of its common stock for approximately $165.0 million and $265.1 million, respectively. As of September 28, 2019, $132.8 million remains available for repurchasesrespectively, under the currentprior share repurchase program. See Note 15 for information regarding the new share repurchase program which was announced by the Company on October 31, 2019.

During
9. COMMITMENTS AND CONTINGENT LIABILITIES

Legal Matters
The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the threeamount of the loss. The Company reviews these accruals and six months ended September 29, 2018,adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period in which such determination is made.

The Company repurchased approximately 1.1 million sharesis involved in various legal proceedings and 2.3 million shares, respectively,claims that have arisen in the ordinary course of its common stock for approximately $86.7 millionbusiness that have not been fully adjudicated. These actions, when finally concluded and $186.7 million, respectively.determined, will not, in the opinion of management, have a material adverse effect upon the Company’s consolidated financial position or results of operations.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


910. REVENUE

The following table presents the Company's revenue disaggregated by geography, based on the location of the customers' headquarters (in thousands):
 Three Months Ended Six Months Ended
 October 3, 2020 September 28, 2019 October 3, 2020 September 28, 2019
United States$459,416
 $452,926
 $707,661
 $720,422
China391,011
 199,945
 778,233
 561,088
Other Asia102,548
 78,606
 160,645
 148,615
Taiwan53,350
 38,044
 106,679
 79,033
Europe53,967
 37,177
 94,525
 73,138
Total revenue$1,060,292
 $806,698
 $1,847,743
 $1,582,296
 Three Months Ended Six Months Ended
 September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018
United States$452,926
 $423,844
 $720,422
 $693,298
China199,945
 304,115
 561,088
 588,273
Other Asia78,606
 60,438
 148,615
 113,930
Taiwan38,044
 54,199
 79,033
 106,895
Europe37,177
 41,847
 73,138
 74,717
Total revenue$806,698
 $884,443
 $1,582,296
 $1,577,113

During the first quarter of fiscal 2020, the Company changed its presentation of net revenue based on the "sold to" address of the customer to the above presentation of net revenue based on the location of the customers' headquarters. The September 29, 2018 information above has been reclassified to reflect this change. The Company believes that the disaggregation of revenue based on the location of the customers' headquarters is more representative of how its revenue and cash flows are impacted by geographically-sensitive changes in economic factors.

The Company also disaggregates revenue by operating segments (see Note 11)12).

1011. RESTRUCTURING

In the third quarter ofDuring fiscal 2019, the Company initiated restructuring actions to reduce operating expenses and improve its manufacturing cost structure, including the phased closure of a wafer fabrication facility in Florida and idling production at a wafer fabrication facility in Texas.  As a result of these restructuring actions, the Company expects to record totalhas recorded cumulative restructuring related charges totaling $92.8 million as of approximately $95.0 million,the end of the second quarter of fiscal 2021, including accelerated depreciation of $49.0$47.4 million (to reflect changes in estimated useful lives of certain property and equipment), impairment charges of $16.0$15.9 million (to adjust the carrying value of certain property and equipment to reflect its fair value), employee termination benefits of $16.0$13.6 million and other exit costs of $14.0$15.9 million.  As of the end of the second quarter of fiscal 2020, theThe Company has recorded cumulativeexpects to record additional expenses of approximately $42.9$0.4 million $16.0 million, $12.3 million and $6.9 million for accelerated depreciation, impairment charges, employee termination benefits and other exit costs respectively, as a result of these restructuring actions (which are expected to be substantially completed by the end of fiscal 2020).

During fiscal 2018, the Company initiated restructuring actions to improve operating efficiencies. As of the end of the second quarter of fiscal 2020, the Company has recorded cumulative expenses of $46.3 million, $23.4 million and $0.2 million for impairment charges, employee termination benefits and other exit costs, respectively, as a result of these restructuring actions. The Company believes these amounts approximate the total costs to be recognized as these restructuring actions are substantially complete.

In addition, the Company recorded immaterial restructuring expenses in the three and six months ended September 28, 2019 and September 29, 2018, related to exited leased facilities associated with other restructuring events.

The Company does not allocatefollowing table summarizes the restructuring costscharges resulting from the 2019 restructuring event (in thousands):
 Three Months Ended October 3, 2020 Three Months Ended September 28, 2019
 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total
One-time employee termination benefits (1)
$0
 $(289) $(289) $0
 $1,364
 $1,364
Contract termination and other associated costs0
 233
 233
 1,034
 1,214
 2,248
Accelerated depreciation0
 0
 0
 5,578
 0
 5,578
Total$0
 $(56) $(56) $6,612
 $2,578
 $9,190
            
 Six Months Ended October 3, 2020 Six Months Ended September 28, 2019
 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total
One-time employee termination benefits (1)
$0
 $(43) $(43) $0
 $4,614
 $4,614
Contract termination and other associated costs0
 858
 858
 2,870
 3,982
 6,852
Accelerated depreciation
0
 0
 0
 21,516
 0
 21,516
Total$0
 $815
 $815
 $24,386
 $8,596
 $32,982

(1) Includes reversal due to its reportable segments.true-up of previously accrued restructuring charges.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

The Company has entered into other individually immaterial restructuring plans. The Company's restructuring charges related to these plans was $0.7 million for the three and six months ended October 3, 2020 and $0.3 million and $0.4 million for the three and six months ended September 28, 2019, respectively.

The following table summarizes the restructuring activity primarily resulting from these restructuring events:
 Three Months Ended September 28, 2019 Three Months Ended September 29, 2018
 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total
One-time employee termination benefits$
 $1,414
 $1,414
 $
 $497
 $497
Contract termination and other associated costs1,035
 1,414
 2,449
 
 13
 13
Accelerated depreciation5,578
 
 5,578
 
 
 
Total$6,613
 $2,828
 $9,441
 $
 $510
 $510
            
 Six Months Ended September 28, 2019 Six Months Ended September 29, 2018
 Cost of Goods Sold Other Operating Expense Total Cost of Goods Sold Other Operating Expense Total
One-time employee termination benefits$
 $4,809
 $4,809
 $
 $3,135
 $3,135
Contract termination and other associated costs2,870
 4,215
 7,085
 
 177
 177
Accelerated depreciation21,516
 
 21,516
 
 
 
Total$24,386
 $9,024
 $33,410
 $
 $3,312
 $3,312

The following table presents a roll-forward ofrelated to the Company's restructuring liabilities for the six months ended September 28, 2019:October 3, 2020 (in thousands):
One-Time Employee Termination Benefits Accelerated Depreciation Contract Termination and Other Associated Costs TotalOne-Time Employee Termination Benefits Contract Termination and Other Associated Costs Total
Accrued restructuring balance as of March 30, 2019$6,988
 $
 $1,626
 $8,614
Accrued restructuring balance as of March 28, 2020$1,728
 $270
 $1,998
Costs incurred and charged to expense4,809
 21,516
 7,085
 33,410
539
 1,008
 1,547
Transfer to right-of-use asset
 
 (1,248) (1,248)
Cash payments(5,115) 
 (4,269) (9,384)(1,089) (949) (2,038)
Non-cash activity
 (21,516) (2,870) (24,386)0
 (113) (113)
Accrued restructuring balance as of September 28, 2019$6,682
 $
 $324
 $7,006
Accrued restructuring balance as of October 3, 2020$1,178
 $216
 $1,394


11.12. OPERATING SEGMENT INFORMATION

The Company's operating and reportable segments as of September 28, 2019October 3, 2020 are Mobile Products (MP)("MP") and Infrastructure and Defense Products (IDP)("IDP") based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on non-GAAP operating income.

MP is a global supplier of cellular, radio frequency ("RF")UWB and Wi-Fi solutions for a variety of mobile devices,high-volume markets, including smartphones, wearables, laptops, tablets and cellular-based applications for the Internet of Things ("IoT").IoT applications.

IDP is a global supplier of RF, system-on-a-chip and power management solutions for cellular base station,wireless infrastructure, defense, smart home, IoT and other wireless communications, defense, automotive, and multiple analog power management applications.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

IoT.

The “All other”"All other" category includes operating expenses such as stock-based compensation, amortization of intangible assets, acquisition and integration related costs, restructuring costs,related charges, start-up costs, asset impairment and accelerated depreciation, gain (loss) gain on assets, and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Except as discussed above regarding the “All other”"All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the “All other” category (in thousands):
 Three Months Ended Six Months Ended
 September 28,
2019
 September 29,
2018
 September 28,
2019
 September 29,
2018
Revenue:       
MP$623,106
 $666,539
 $1,179,359
 $1,152,618
IDP183,592
 217,904
 402,937
 424,495
Total revenue$806,698
 $884,443
 $1,582,296
 $1,577,113
Operating income (loss):       
MP$193,431
 $196,948
 $333,366
 $286,119
IDP14,969
 56,311
 65,093
 111,515
All other(95,633) (162,782) (230,466) (326,372)
Operating income112,767
 90,477
 167,993
 71,262
Interest expense(12,693) (9,689) (24,557) (24,042)
Interest income2,292
 1,580
 5,238
 4,974
Other expense (Note 7)
(300) (49,532) (1,411) (81,487)
Income (loss) before income taxes$102,066
 $32,836
 $147,263
 $(29,293)

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

 Three Months Ended Six Months Ended
 October 3,
2020
 September 28,
2019
 October 3,
2020
 September 28,
2019
Revenue:       
MP$754,294
 $623,106
 $1,222,698
 $1,179,359
IDP305,998
 183,592
 625,045
 402,937
Total revenue$1,060,292
 $806,698
 $1,847,743
 $1,582,296
Operating income (loss):       
MP$262,858
 $193,431
 $372,841
 $333,366
IDP66,495
 14,969
 160,250
 65,093
All other(107,709) (95,633) (218,735) (230,466)
Operating income221,644
 112,767
 314,356
 167,993
Interest expense(23,486) (12,693) (42,335) (24,557)
Interest income1,272
 2,292
 2,462
 5,238
Other income (expense), net648
 (300) 22,595
 (1,411)
Income before income taxes$200,078
 $102,066
 $297,078
 $147,263

 
Three Months Ended Six Months EndedThree Months Ended Six Months Ended
September 28,
2019
 September 29,
2018
 September 28,
2019
 September 29,
2018
October 3,
2020
 September 28,
2019
 October 3,
2020
 September 28,
2019
Reconciliation of “All other” category:              
Stock-based compensation expense$(20,876) $(20,905) $(45,829) $(40,250)$(30,048) $(20,876) $(51,907) $(45,829)
Amortization of intangible assets(56,288) (133,116) (114,470) (266,291)(72,147) (56,288) (144,091) (114,470)
Acquisition and integration related costs(7,549) (1,098) (30,679) (2,180)(7,259) (7,549) (19,922) (30,679)
Restructuring costs(3,863) (510) (11,894) (3,312)
Start-up costs(4) (5,883) (100) (11,244)
Asset impairment and accelerated depreciation(6,635) 
 (22,573) 
Other (including (loss) gain on assets and other miscellaneous corporate overhead)(418) (1,270) (4,921) (3,095)
Restructuring related charges(609) (3,863) (1,547) (11,894)
Accelerated depreciation0
 (6,635) 0
 (22,573)
Other (including gain (loss) on assets, start-up costs and other miscellaneous corporate overhead)2,354
 (422) (1,268) (5,021)
Loss from operations for “All other”$(95,633) $(162,782) $(230,466) $(326,372)$(107,709) $(95,633) $(218,735) $(230,466)


1213. INCOME TAXES

Income Tax Expense
The Company’s provision for income taxes for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018 was calculated by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pre-

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


tax(pre-tax income or loss excluding unusual or infrequently occurring discrete items) for those respective periods.

The Company’s income tax expense was $63.2 million for the three and six months ended September 28, 2019October 3, 2020, and September 29, 2018.

Thethe Company’s income tax expense was $19.0 million and $24.7 million, respectively, for the three and six months ended September 28, 2019,2019. The Company’s effective tax rate was 31.6% and the Company’s income tax expense was $0.8 million and income tax benefit was $31.4 million,21.3% for the three and six months ended September 29, 2018, respectively. The Company’s effective tax rate wasOctober 3, 2020, respectively, and 18.6% and 16.8% for the three and six months ended September 28, 2019, respectively, and 2.3% and 107.1% for the three and six months ended September 29, 2018, respectively.

The Company's effective tax rate for the three and six months ended September 28, 2019October 3, 2020 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, global intangible low tax income (“GILTI”), domestic tax credits generated, and discrete tax items recorded during the period. A discrete charge of $45.2 million and $35.2 million was recorded during the three and six months ended October 3, 2020, respectively. The discrete charge primarily relates to the intercompany restructuring of the Cavendish intellectual property, partially offset by discrete tax benefits recognized for stock-based compensation deductions and a retroactive incentive allowing previously non-deductible payments to be amortized. The Company's effective tax rate for the three and six months ended September 28, 2019 differed from the statutory rate primarily

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)

due to tax rate differences in foreign jurisdictions, GILTI, domestic tax credits generated, foreign permanent differences, the discrete treatment of postcombinationpost-combination compensation related expenses relateddue to the Active-Semi acquisition, and a discrete expense related to the Company’s change in its permanent reinvestment assertion for certain unrepatriated foreign earnings previously subject to U.S. federal taxation. The Company's effective tax rate for the three and six months ended September 29, 2018 differed from the statutory rate primarily due to tax rate differences in foreign jurisdictions, foreign permanent differences, state income taxes, domestic tax credits generated, changes in unrecognized tax benefits, GILTI, a discrete tax benefit for changes in provisional estimates related to the one-time transition tax on certain unrepatriated earnings of foreign subsidiaries enacted in the Tax Cuts and Jobs Act and a discrete tax benefit resulting from a retroactive incentive allowing previously non-deductible payments to be amortized.

Management has concluded that it can no longer support an assertion that certain earnings which have previously been subject to U.S. federal taxation at its foreign subsidiaries are permanently reinvested. During the second quarter of fiscal 2020, the Company updated forecasts of cash balances and cash flow outside the U.S. and began to implement a more centralized approach to cash management. As a result, the Company recorded $4.0 million discrete tax expense during the second quarter of fiscal 2020. The Company had previously released in the third quarter of fiscal 2018 its permanent reinvestment assertion on its operating subsidiary in Singapore, Qorvo International Pte. Ltd.

1314. NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share (in thousands, except per share data):
Three Months Ended Six Months EndedThree Months Ended Six Months Ended
September 28, 2019 September 29, 2018 September 28, 2019 September 29, 2018October 3, 2020 September 28, 2019 October 3, 2020 September 28, 2019
Numerator:              
Numerator for basic and diluted net income per share — net income available to common stockholders$83,038
 $32,084
 $122,579
 $2,091
$136,917
 $83,038
 $233,839
 $122,579
Denominator:              
Denominator for basic net income per share — weighted average shares117,294
 125,643
 117,945
 125,859
114,328
 117,294
 114,388
 117,945
Effect of dilutive securities:              
Stock-based awards2,135
 2,907
 2,251
 3,118
1,849
 2,135
 2,007
 2,251
Denominator for diluted net income per share — adjusted weighted average shares and assumed conversions119,429
 128,550
 120,196
 128,977
116,177
 119,429
 116,395
 120,196
Basic net income per share$0.71
 $0.26
 $1.04
 $0.02
$1.20
 $0.71
 $2.04
 $1.04
Diluted net income per share$0.70
 $0.25
 $1.02
 $0.02
$1.18
 $0.70
 $2.01
 $1.02


In the computation of diluted net income per share for the three and six months ended October 3, 2020, approximately 0.3 million and 0.1 million outstanding shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the three and six months ended September 28, 2019, approximately 0.4 million and 0.2 million outstanding shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for the three and six months ended September 29, 2018,

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


approximately 0.3 million and 0.2 million outstanding shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive.

14. CONDENSED CONSOLIDATING FINANCIAL INFORMATION15. SUBSEQUENT EVENT

In accordancePrior to October 3, 2020, in connection with the applicable indentures governingoffering of the 2025 Notes and 20262031 Notes, the Company's obligations under the 2025 Notes and 2026 Notes are fully and unconditionally guaranteed on a joint and several basis by each Guarantor, each of which is 100% owned, directly or indirectly, by Qorvo, Inc. (the "Parent Company"). A Guarantor can be released in certain customary circumstances.

The following presents the condensed consolidating financial information separately for:
(i)Parent Company, the issuer of the guaranteed obligations;
(ii)Guarantor subsidiaries, on a combined basis, as specified in the applicable indenture;
(iii)Non-guarantor subsidiaries, on a combined basis;
(iv)Consolidating entries, eliminations and reclassifications representing adjustmentsCompany delivered to (a) eliminate intercompany transactions between or among the Parent Company, the Guarantor subsidiaries and the non-guarantor subsidiaries, (b) eliminate intercompany profit in inventory, (c) eliminate the investments in the Company’s subsidiaries and (d) record consolidating entries; and
(v)The Company, on a consolidated basis.

Each entity in the condensed consolidating financial information follows the same accounting policies as described in the consolidated financial statements, except for the use by the Parent Company and Guarantor subsidiaries of the equity method of accounting to reflect ownership interests in subsidiaries that are eliminated upon consolidation. The financial information may not necessarily be indicative of the financial position, results of operations, comprehensive (loss) income, and cash flows, had the Parent Company, Guarantor or non-guarantor subsidiaries operated as independent entities.

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)



 Condensed Consolidating Balance Sheet
 September 28, 2019
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
ASSETS         
Current assets:         
Cash and cash equivalents$
 $80,065
 $506,729
 $
 $586,794
Accounts receivable, less allowance
 43,952
 361,156
 
 405,108
Intercompany accounts and notes receivable
 473,809
 4,624
 (478,433) 
Inventories
 165,456
 341,741
 (21,913) 485,284
Prepaid expenses
 20,793
 6,493
 
 27,286
Other receivables
 1,799
 12,338
 
 14,137
Other current assets
 29,930
 3,275
 
 33,205
Total current assets
 815,804
 1,236,356
 (500,346) 1,551,814
Property and equipment, net
 1,059,674
 233,337
 3,092
 1,296,103
Goodwill
 1,122,629
 1,182,507
 
 2,305,136
Intangible assets, net
 154,482
 297,306
 
 451,788
Long-term investments
 5,537
 92,012
 
 97,549
Long-term intercompany accounts and notes receivable
 1,341,488
 220,231
 (1,561,719) 
Investment in subsidiaries6,716,288
 2,591,241
 
 (9,307,529) 
Other non-current assets6,635
 101,258
 43,286
 (4,998) 146,181
Total assets$6,722,923
 $7,192,113
 $3,305,035
 $(11,371,500) $5,848,571
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable$
 $70,435
 $143,501
 $
 $213,936
Intercompany accounts and notes payable
 4,624
 473,809
 (478,433) 
Accrued liabilities10,854
 114,289
 45,578
 1,624
 172,345
Current portion of long-term debt3,750
 
 483
 
 4,233
Other current liabilities
 10,167
 48,948
 
 59,115
Total current liabilities14,604
 199,515
 712,319
 (476,809) 449,629
Long-term debt1,014,423
 
 1,640
 
 1,016,063
Long-term intercompany accounts and notes payable1,428,402
 133,317
 
 (1,561,719) 
Other long-term liabilities
 114,388
 28,440
 (25,443) 117,385
Total liabilities2,457,429
 447,220
 742,399
 (2,063,971) 1,583,077
Total stockholders’ equity4,265,494
 6,744,893
 2,562,636
 (9,307,529) 4,265,494
Total liabilities and stockholders’ equity$6,722,923
 $7,192,113
 $3,305,035
 $(11,371,500) $5,848,571


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


 Condensed Consolidating Balance Sheet
 March 30, 2019
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
ASSETS         
Current assets:         
Cash and cash equivalents$
 $231,865
 $479,170
 $
 $711,035
Accounts receivable, less allowance
 47,181
 330,991
 
 378,172
Intercompany accounts and notes receivable
 381,558
 62,640
 (444,198) 
Inventories
 173,885
 359,252
 (21,344) 511,793
Prepaid expenses
 24,087
 1,679
 
 25,766
Other receivables
 5,121
 16,813
 
 21,934
Other current assets
 33,956
 2,354
 (169) 36,141
Total current assets
 897,653
 1,252,899
 (465,711) 1,684,841
Property and equipment, net
 1,090,171
 268,040
 8,302
 1,366,513
Goodwill
 1,122,629
 1,051,260
 
 2,173,889
Intangible assets, net
 214,348
 193,862
 
 408,210
Long-term investments
 4,969
 92,817
 
 97,786
Long-term intercompany accounts and notes receivable
 1,239,474
 93,923
 (1,333,397) 
Investment in subsidiaries6,540,081
 2,321,170
 
 (8,861,251) 
Other non-current assets17,245
 46,784
 28,234
 (15,478) 76,785
Total assets$6,557,326
 $6,937,198
 $2,981,035
 $(10,667,535) $5,808,024
LIABILITIES AND STOCKHOLDERS’ EQUITY        
Current liabilities:        
Accounts payable$
 $95,089
 $138,218
 $
 $233,307
Intercompany accounts and notes payable
 62,640
 381,558
 (444,198) 
Accrued liabilities11,174
 96,238
 51,781
 1,323
 160,516
Current portion of long-term debt
 
 80
 
 80
Other current liabilities
 
 41,880
 (169) 41,711
Total current liabilities11,174
 253,967
 613,517
 (443,044) 435,614
Long-term debt919,270
 
 1,665
 
 920,935
Long-term intercompany accounts and notes payable1,267,203
 66,195
 
 (1,333,398) 
Other long-term liabilities
 76,955
 45,202
 (30,361) 91,796
Total liabilities2,197,647
 397,117
 660,384
 (1,806,803) 1,448,345
Total stockholders’ equity4,359,679
 6,540,081
 2,320,651
 (8,860,732) 4,359,679
Total liabilities and stockholders’ equity$6,557,326
 $6,937,198
 $2,981,035
 $(10,667,535) $5,808,024



QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


 Condensed Consolidating Statement of Income and Comprehensive Income
 Three Months Ended September 28, 2019
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Revenue$
 $215,097
 $749,581
 $(157,980) $806,698
Cost of goods sold
 193,994
 423,834
 (134,712) 483,116
Gross profit
 21,103
 325,747
 (23,268) 323,582
Operating expenses:        
Research and development7,113
 (4,054) 113,453
 (898) 115,614
Selling, general and administrative13,763
 44,710
 51,819
 (22,018) 88,274
Other operating expense
 4,497
 2,418
 12
 6,927
Total operating expenses20,876
 45,153
 167,690
 (22,904) 210,815
Income (loss) from operations(20,876) (24,050) 158,057
 (364) 112,767
Interest expense(12,496) (577) (103) 483
 (12,693)
Interest income
 648
 2,128
 (484) 2,292
Other (expense) income
 (679) 379
 
 (300)
Income (loss) before income taxes(33,372) (24,658) 160,461
 (365) 102,066
Income tax (expense) benefit7,359
 (4,183) (22,204) 
 (19,028)
Income in subsidiaries109,051
 138,256
 
 (247,307) 
Net income$83,038
 $109,415
 $138,257
 $(247,672) $83,038
          
Comprehensive income$82,061
 $109,510
 $136,942
 $(246,452) $82,061
 Condensed Consolidating Statement of Income and Comprehensive Income
 Three Months Ended September 29, 2018
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Revenue$
 $236,631
 $825,844
 $(178,032) $884,443
Cost of goods sold
 207,221
 476,256
 (152,548) 530,929
Gross profit
 29,410
 349,588
 (25,484) 353,514
Operating expenses:         
Research and development6,910
 7,340
 103,671
 (1,173) 116,748
Selling, general and administrative13,876
 58,924
 91,399
 (24,692) 139,507
Other operating expense (income)119
 (2,192) 8,458
 397
 6,782
Total operating expenses20,905
 64,072
 203,528
 (25,468) 263,037
Income (loss) from operations(20,905) (34,662) 146,060
 (16) 90,477
Interest expense(9,400) (522) (160) 393
 (9,689)
Interest income
 477
 1,495
 (392) 1,580
Other (expense) income(48,779) 798
 (1,551) 
 (49,532)
Income (loss) before income taxes(79,084) (33,909) 145,844
 (15) 32,836
Income tax (expense) benefit25,920
 (20,470) (6,202) 
 (752)
Income in subsidiaries85,248
 139,642
 
 (224,890) 
Net income$32,084
 $85,263
 $139,642
 $(224,905) $32,084
          
Comprehensive income$32,012
 $85,347
 $139,472
 $(224,819) $32,012

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


 Condensed Consolidating Statement of Income and Comprehensive Income
 Six Months Ended September 28, 2019
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Revenue$
 $472,039
 $1,474,695
 $(364,438) $1,582,296
Cost of goods sold
 437,864
 843,949
 (317,388) 964,425
Gross profit
 34,175
 630,746
 (47,050) 617,871
Operating expenses:         
Research and development14,002
 11,529
 210,721
 (1,718) 234,534
Selling, general and administrative31,827
 94,992
 95,643
 (45,209) 177,253
Other operating expense
 19,321
 18,960
 (190) 38,091
Total operating expenses45,829
 125,842
 325,324
 (47,117) 449,878
Income (loss) from operations(45,829) (91,667) 305,422
 67
 167,993
Interest expense(24,085) (1,069) (278) 875
 (24,557)
Interest income
 1,406
 4,707
 (875) 5,238
Other expense
 (107) (1,304) 
 (1,411)
Income (loss) before income taxes(69,914) (91,437) 308,547
 67
 147,263
Income tax (expense) benefit15,165
 (1,443) (38,406) 
 (24,684)
Income in subsidiaries177,328
 270,140
 
 (447,468) 
Net income$122,579
 $177,260
 $270,141
 $(447,401) $122,579
          
Comprehensive income$121,545
 $177,355
 $268,833
 $(446,188) $121,545
 Condensed Consolidating Statement of Income and Comprehensive (Loss) Income
 Six Months Ended September 29, 2018
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Revenue$
 $468,570
 $1,451,805
 $(343,262) $1,577,113
Cost of goods sold
 397,532
 885,953
 (296,619) 986,866
Gross profit
 71,038
 565,852
 (46,643) 590,247
Operating expenses:         
Research and development13,311
 10,619
 206,119
 (2,398) 227,651
Selling, general and administrative26,671
 116,880
 177,778
 (45,892) 275,437
Other operating expense269
 5,748
 9,512
 368
 15,897
Total operating expenses40,251
 133,247
 393,409
 (47,922) 518,985
Income (loss) from operations(40,251) (62,209) 172,443
 1,279
 71,262
Interest expense(23,442) (1,059) (321) 780
 (24,042)
Interest income
 2,883
 2,870
 (779) 4,974
Other (expense) income(82,152) 1,126
 (461) 
 (81,487)
(Loss) income before income taxes(145,845) (59,259) 174,531
 1,280
 (29,293)
Income tax benefit (expense)37,374
 (3,666) (2,324) 
 31,384
Income in subsidiaries110,562
 172,207
 
 (282,769) 
Net income$2,091
 $109,282
 $172,207
 $(281,489) $2,091
          
Comprehensive (loss) income$(165) $109,371
 $169,727
 $(279,098) $(165)


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)



 Condensed Consolidating Statement of Cash Flows
 Six Months Ended September 28, 2019
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Net cash provided by (used in) operating activities$166,127
 $(144,146) $408,549
 $
 $430,530
Investing activities:         
Purchase of property and equipment
 (75,365) (12,973) 
 (88,338)
Purchase of a business, net of cash acquired
 
 (299,673) 
 (299,673)
Proceeds from sale of available-for-sale debt securities
 1,950
 
 
 1,950
Other investing activities
 (1,748) 506
 
 (1,242)
Net transactions with related parties
 28,086
 
 (28,086) 
Net cash used in investing activities
 (47,077) (312,140) (28,086) (387,303)
Financing activities:        
Proceeds from borrowings100,000
 
 
 
 100,000
Repurchase of common stock, including transaction costs(265,105) 
 
 
 (265,105)
Proceeds from the issuance of common stock20,205
 
 
 
 20,205
Tax withholding paid on behalf of employees for restricted stock units(20,545) 
 
 
 (20,545)
Other financing activities(682) 
 (150) 
 (832)
Net transactions with related parties
 39,423
 (67,509) 28,086
 
Net cash (used in) provided by financing activities(166,127) 39,423
 (67,659) 28,086
 (166,277)
Effect of exchange rate changes on cash
 
 (1,091) 
 (1,091)
Net (decrease) increase in cash, cash equivalents and restricted cash
 (151,800) 27,659
 
 (124,141)
Cash, cash equivalents and restricted cash at the beginning of the period
 231,865
 479,517
 
 711,382
Cash, cash equivalents and restricted cash at the end of the period$
 $80,065
 $507,176
 $
 $587,241
          


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


 Condensed Consolidating Statement of Cash Flows
 Six Months Ended September 29, 2018
(in thousands)Parent Company Guarantor Subsidiaries Non-Guarantor Subsidiaries Eliminations and Reclassifications Consolidated
Net cash provided by (used in) operating activities$522,959
 $(548,315) $315,152
 $
 $289,796
Investing activities:         
Purchase of property and equipment
 (95,897) (17,769) 
 (113,666)
Purchase of available-for-sale debt securities
 (132,729) 
 
 (132,729)
Proceeds from maturities and sales of available-for-sale debt securities
 133,132
 
 
 133,132
Other investing activities
 (1,086) (18,406) 
 (19,492)
Net transactions with related parties
 110,047
 
 (110,047) 
Net cash (used in) provided by investing activities
 13,467
 (36,175) (110,047) (132,755)
Financing activities:        
Repurchase of debt(954,745) 
 
 
 (954,745)
Proceeds from debt issuances631,300
 
 
 
 631,300
Repurchase of common stock, including transaction costs(186,682) 
 
 
 (186,682)
Proceeds from the issuance of common stock18,406
 
 
 
 18,406
Tax withholding paid on behalf of employees for restricted stock units(24,181) 
 
 
 (24,181)
Other financing activities(7,057) 
 
 
 (7,057)
Net transactions with related parties
 686
 (110,733) 110,047
 
Net cash (used in) provided by financing activities(522,959) 686
 (110,733) 110,047
 (522,959)
Effect of exchange rate changes on cash
 
 (2,216) 
 (2,216)
Net (decrease) increase in cash, cash equivalents and restricted cash
 (534,162) 166,028
 
 (368,134)
Cash, cash equivalents and restricted cash at the beginning of the period
 629,314
 297,088
 
 926,402
Cash, cash equivalents and restricted cash at the end of the period$
 $95,152
 $463,116
 $
 $558,268


15. SUBSEQUENT EVENTS

Senior Notes due 2029
On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the “2029 Notes”). The 2029 Notes pay interest semi-annually on April 15 and October 15 at a rate of 4.375% per annum. The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms.

The 2029 Notes were sold in a private offering to certain institutions that then resold the 2029 Notes in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act, and to certain non-U.S. persons in accordance with Regulation S under the Securities Act. The Company intends to use the net proceeds of the offering for general corporate purposes. The 2029 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by each of the Guarantors.


QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


The 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019 (the “2019 Indenture”), by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee. The 2019 Indenture contains customary eventstrustee, a Notice of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2019 Indenture also contains customary negative covenants.

At any time prior toRedemption for the $900.0 million principal balance of the 2026 Notes. On October 15, 2024,16, 2020, the Company may redeem all or partcompleted the redemption of the 20292026 Notes at a redemption price equal to their106.363% of the principal amount, plus a “make-whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to October 15, 2024, the Company may redeem up to 35% of the original aggregate principal amount of the 2029 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 104.375%, plus accrued and unpaid interest. Furthermore, at any timeinterest, for a total cash payment of $969.8 million. The 2026 Notes were redeemed using proceeds from the recent issuance of the 2031 Notes combined with cash on or after October 15, 2024,hand plus borrowings under the Company may redeem the 2029 Notes, in whole or in part, at the redemption prices specified in the 2019 Indenture, plus accrued and unpaid interest.2020 Term Loan.

The 2029principal balance of the 2026 Notes have not been registered under the Securities Act, or any state securities laws, and, unless so registered, may not be offered or soldwas reclassified as of October 3, 2020 from "Long-term debt" to "Current portion of long-term debt" in the United States absent registration or an applicable exemption fromCondensed Consolidated Balance Sheet due to the registration requirements ofCompany's intention to retire the Securities Act and applicable state securities laws.obligation soon after the balance sheet date.

In connection with the offering of the 2029 Notes, the Company entered into a Registration Rights Agreement, dated as of September 30, 2019 (the “Registration Rights Agreement”), by and among the Company and the Guarantors, on the one hand, and BofA Securities, Inc., as representative of the initial purchasers of the 2029 Notes, on the other hand.

Under the Registration Rights Agreement, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file with the SEC a registration statement (the “Exchange Offer Registration Statement”) relating to the registered exchange offer (the “Exchange Offer”) to exchange the 2029 Notes for a new series of the Company’s exchange notes having terms substantially identical in all material respects to, and in the same aggregate principal amount as, the 2029 Notes; (ii) cause the Exchange Offer Registration Statement to be declared effective by the SEC; and (iii) cause the Exchange Offer to be consummated no later than the 360th day after September 30, 2019 (or if such 360th day is not a business day, the next succeeding business day). The Company and the Guarantors have also agreed to use their commercially reasonable efforts to cause the Exchange Offer Registration Statement to be effective continuously and keep the Exchange Offer open for a period of not less than the minimum period required under applicable federal and state securities laws to consummate the Exchange Offer.

Under certain circumstances, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file a shelf registration statement relating to the resale of the 2029 Notes as promptly as practicable, and (ii) cause the shelf registration statement to be declared effective by the SEC as promptly as practicable. The Company and the Guarantors have also agreed to use their commercially reasonable efforts to keep the shelf registration statement continuously effective until one year after its effective date (or such shorter period that will terminate when all the 2029 Notes covered thereby have been sold pursuant thereto).

If the Company fails to meet any of these targets, the annual interest rate on the 2029 Notes will increase by 0.25% during the 90-day period following the default, and will increase by an additional 0.25% for each subsequent 90-day period during which the default continues, up to a maximum additional interest rate of 1.00% per year. If the Company cures the default, the interest rate on the 2029 Notes will revert to the original level.

Cavendish Kinetics Limited Acquisition
On October 4, 2019, the Company completed the acquisition of the entire issued and outstanding capital of Cavendish for a cash purchase price of approximately $203.0 million, subject to customary purchase price adjustments. Cavendish is a private supplier of high-performance RF microelectromechanical system ("MEMS") technology for antenna tuning applications and will become part of the Company's MP operating segment. As a result of the acquisition, RF MEMS technology will be advanced for applications across the Company's products and the technology will be transitioned into high-volume manufacturing for mobile devices and other markets.

Share Repurchase Program
On October 31, 2019, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $1.0 billion of the Company's outstanding common stock, which includes approximately $117.0 million authorized under the prior program terminated concurrent with the new authorization. Under this new program, share

QORVO, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


repurchases will be made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases will depend on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations and contentions, and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential,

"potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements included herein represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those expressed or implied by forward-looking statements. We do not intend to update any of these forward-looking statements or publicly announce the results of any revisions to these forward-looking statements, other than as is required under U.S. federal securities laws. Our business is subject to numerous risks and uncertainties, including those relating to fluctuations in our operating results; our substantial dependence on developing new products and achieving design wins; our dependence on a few large customers for a substantial portion of our revenue; a loss of revenue if contracts with the United States government or defense and aerospace contractors are canceled or delayed or if defense spending is reduced; the COVID-19 pandemic, which has and will likely continue to negatively impact the global economy and disrupt normal business activities, and which may have an adverse effect on our results of operations; our dependence on third parties; risks related to sales through distributors; risks associated with the operation of our manufacturing facilities; business disruptions; poor manufacturing yields; increased inventory risks and costs due to timing of customer forecasts; our inability to effectively manage or maintain evolving relationships with platform providers; risks from international sales and operations; economic regulation in China; changes in government trade policies, including imposition of tariffs and export restrictions; our ability to implement innovative technologies; underutilization of manufacturing facilities as a result of industry overcapacity; we may not be able to borrow funds under our credit facility or secure future financing; we may not be able to generate sufficient cash to service all of our debt; restrictions imposed by the agreements governing our debt; volatility in the price of our common stock; damage to our reputation or brand; fluctuations in the amount and frequency of our stock repurchases; our recent and future acquisitions and other strategic investments including our recent acquisitions of Active-Semi International, Inc. ("Active-Semi") and Cavendish Kinetics Limited ("Cavendish"), could fail to achieve financial or strategic objectives; our ability to attract, retain and motivate key employees; our reliance on our intellectual property portfolio; claims of infringement of third-party intellectual property rights; security breaches and other similar disruptions compromising our information; theft, loss or misuse of personal data by or about our employees, customers or third parties; warranty claims, product recalls and product liability; and risks associated with environmental, health and safety regulations and climate change. Many of the foregoing risks and uncertainties are, and will continue to be exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. These and other risks and uncertainties, which are described in more detail in our most recent Annual Report on Form 10-K and in other reports and statements that we file with the SEC, could cause actual results and developments to be materially different from those expressed or implied by any of these forward-looking statements.

OVERVIEW

Company

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to help the reader understand the consolidated results of operations and financial condition of Qorvo. MD&A is provided as a supplement to, and should be read in conjunction with, our Condensed Consolidated Financial Statements and accompanying Notes to Condensed Consolidated Financial Statements.

Qorvo®Qorvo® is a productleader in the development and technology leader at the forefrontcommercialization of the growing global demandtechnologies and products for always-onwireless and wired connectivity. We combine a broad portfolio of innovative radio frequency ("RF") solutions, highly differentiated semiconductor technologies, systems-level expertise and global manufacturing scale to supply a diverse groupset of customers in expanding markets, including smartphones and other mobile devices, defense and aerospace, Wi-Fi customer premises equipment, cellular base stations, and multiple Internet of Things ("IoT") applications including the smart home and connected car. Within these markets, our products enable a broad range of leading-edge applications –products that enable a more connected world.

The COVID-19 pandemic and the resulting economic downturn are affecting business conditions in our industry. During the six months ended October 3, 2020, we did not encounter material disruptions to our global supply chain or operations, and we believe that our cash on hand (including from very-high-power wiredour recently issued senior notes), cash flows from operations and wireless infrastructure solutionsavailability under our revolving credit facility provide us with sufficient liquidity. The duration, severity, and future impact of the COVID-19 pandemic remains highly uncertain, however, and may result in significant disruptions to ultra-low-power smart home solutions. Our productsour operations, including our supply chain, as well as negative impacts to our financial condition. We will continue to monitor the implications of the COVID-19 pandemic on our business, as well as our customers' and technologies help transform how people around the world access their data, transact commerce and interact with their communities.suppliers' businesses.

We design, develop, manufacture and market our products to leading U.S. and international original equipment manufacturers and original design manufacturers in the followingtwo operating segments, which are also our reportable segments: Mobile Products ("MP") and Infrastructure and Defense Products ("IDP").

Mobile Products (MP) - MP is a global supplier of cellular RF and Wi-Fi solutions for a variety of mobile devices, including smartphones, wearables, laptops, tablets and cellular-based applications for the IoT.
MP is a global supplier of cellular, ultra-wide band and Wi-Fi solutions for a variety of high-volume markets, including smartphones, wearables, laptops, tablets and Internet of Things ("IoT") applications.

Infrastructure and Defense Products (IDP) - IDP is a global supplier of RF, system-on-a-chip and power management solutions for cellular base station, smart home, IoT and other wireless communications, defense, automotive and multiple analog power management applications.  

AsIDP is a global supplier of September 28, 2019, our reportable segments are MPRF, system-on-a-chip and IDP. power management solutions for wireless infrastructure, defense, smart home, automotive, and IoT.


These business segments are based on the organizational structure and information reviewed by our Chief Executive Officer, who is our chief operating decision maker ("CODM"), and are managed separately based on the end markets and applications they support. The CODM allocates resources and evaluates the performance of each operating segment primarily based on non-GAAP operating income (see Note 1112 of the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this report for additional information regarding our operating segments).

SECOND QUARTER FISCAL 20202021 FINANCIAL HIGHLIGHTS:

Fiscal 2021 is a 53-week fiscal year during which the second fiscal quarter ended October 3, 2020 and included 14 weeks, compared to 13 weeks for the second fiscal quarter ended September 28, 2019. The first six months of fiscal 2021 ended October 3, 2020 and included 27 weeks, compared to 26 weeks for the six months ended September 28, 2019. This additional week impacts the following year-over-year results of operations.

Quarterly revenue decreased 8.8%increased 31.4% as compared to the second quarter of fiscal 2019,2020, primarily due to lower shipments of our mobile products and base station products to Huawei Technologies Co., Ltd. and its affiliates ("Huawei") as well as lowerhigher demand for our mobile products in support of oursmartphone customers based in China. These decreases were partially offset by increased revenue resulting fromChina and Korea, higher demand for marquee smartphones experienced by our largest end customer as well as5G base station products (primarily in China), and higher demand from a Korea-based customer.for our Wi-Fi products.

Gross margin for the second quarter of fiscal 20202021 was 40.1%46.4% as compared to 40.0%40.1% for the second quarter of fiscal 2019, with gross margin improvements related2020, primarily due to overall favorable factory utilization, lower intangible amortization expenseinventory adjustments and favorable changes in product mix beinglower restructuring charges, partially offset by lower factory utilization and increased restructuring charges.average selling price erosion.

Operating income was $221.6 million for the second quarter of fiscal 2021 as compared to $112.8 million for the second quarter of fiscal 20202020. This increase was primarily due to higher revenue and higher gross margin, partially offset by higher operating expenses. Operating expenses increased primarily due to higher personnel costs and increased product development spend resulting from our recent acquisitions.

Net income per diluted share was $1.18 for the second quarter of fiscal 2021 as compared to operating income$0.70 for the second quarter of $90.5fiscal 2020.

Capital expenditures were $43.6 million for the second quarter of fiscal 2019. This increase was primarily due2021 as compared to lower operating expenses, partially offset by lower revenue.$38.0 million for the second quarter of fiscal 2020.

Capital expenditures decreased to $38.0 million for the second quarter of fiscal 2020 as compared to $70.1 million for the second quarter of fiscal 2019. Our capital expenditures in the second quarter of fiscal 2020 were primarily strategic investments in premium filter capacity and gallium nitride ("GaN") technology capabilities.

During the second quarter of fiscal 2020,2021, we repurchased approximately 2.30.8 million shares of our common stock for approximately $165.0$105.0 million.

During the second quarter of fiscal 2021, we completed the acquisition of 7Hugs Labs S.A.S. ("7Hugs") for a total purchase price of $48.7 million, including cash acquired of $1.0 million.

During the second quarter of fiscal 2021, we issued $700.0 million aggregate principal amount of 3.375% senior notes due 2031 (the "2031 Notes").

During the second quarter of fiscal 2021, we entered into a five-year unsecured senior credit facility, which includes a senior term loan (the "2020 Term Loan") of up to $200.0 million. On the closing date, we drew the full amount of the 2020 Term Loan and concurrently repaid the $97.5 million remaining principal balance of the term loan under a previous credit facility (see Note 7 of the Notes to Condensed Consolidated Financial Statements).

Subsequent to quarter end, we completed the redemption of our 5.50% senior notes due July 15, 2026 (the "2026 Notes") at a redemption price equal to 106.363% of the principal amount of $900.0 million, plus accrued and unpaid interest (see Note 15 of the Notes to Condensed Consolidated Financial Statements).






RESULTS OF OPERATIONS

Consolidated

The following table presents a summary of our results of operations for the three and six months ended September 28, 2019October 3, 2020 and September 29, 201828, 2019 (in thousands, except percentages): 
Three Months EndedThree Months Ended
September 28,
2019
 
% of
Revenue
 September 29,
2018
 
% of
Revenue
 Increase (Decrease) 
Percentage
Change
October 3,
2020
 
% of
Revenue
 September 28,
2019
 
% of
Revenue
 Increase (Decrease) 
Percentage
Change
Revenue$806,698
 100.0% $884,443
 100.0% $(77,745) (8.8)%$1,060,292
 100.0% $806,698
 100.0% $253,594
 31.4 %
Cost of goods sold483,116
 59.9
 530,929
 60.0
 (47,813) (9.0)568,742
 53.6
 483,116
 59.9
 85,626
 17.7
Gross profit323,582
 40.1
 353,514
 40.0
 (29,932) (8.5)491,550
 46.4
 323,582
 40.1
 167,968
 51.9
Research and development115,614
 14.3
 116,748
 13.2
 (1,134) (1.0)156,342
 14.8
 115,614
 14.3
 40,728
 35.2
Selling, general and administrative88,274
 10.9
 139,507
 15.8
 (51,233) (36.7)109,372
 10.3
 88,274
 10.9
 21,098
 23.9
Other operating expense6,927
 0.9
 6,782
 0.8
 145
 2.1
4,192
 0.4
 6,927
 0.9
 (2,735) (39.5)
Operating income$112,767
 14.0% $90,477
 10.2% $22,290
 24.6 %$221,644
 20.9% $112,767
 14.0% $108,877
 96.6 %
                      
Six Months EndedSix Months Ended
September 28, 2019 % of Revenue September 29, 2018 % of Revenue Increase (Decrease) Percentage ChangeOctober 3, 2020 % of Revenue September 28, 2019 % of Revenue Increase (Decrease) Percentage Change
Revenue$1,582,296
 100.0% $1,577,113
 100.0% $5,183
 0.3 %$1,847,743
 100.0% $1,582,296
 100.0% $265,447
 16.8 %
Cost of goods sold964,425
 61.0
 986,866
 62.6
 (22,441) (2.3)1,030,404
 55.8
 964,425
 61.0
 65,979
 6.8
Gross profit617,871
 39.0
 590,247
 37.4
 27,624
 4.7
817,339
 44.2
 617,871
 39.0
 199,468
 32.3
Research and development234,534
 14.8
 227,651
 14.4
 6,883
 3.0
286,413
 15.5
 234,534
 14.8
 51,879
 22.1
Selling, general and administrative177,253
 11.2
 275,437
 17.5
 (98,184) (35.6)195,976
 10.6
 177,253
 11.2
 18,723
 10.6
Other operating expense38,091
 2.4
 15,897
 1.0
 22,194
 139.6
20,594
 1.1
 38,091
 2.4
 (17,497) (45.9)
Operating income$167,993
 10.6% $71,262
 4.5% $96,731
 135.7 %$314,356
 17.0% $167,993
 10.6% $146,363
 87.1 %
                      
Revenue decreasedincreased for the three months ended September 28, 2019,October 3, 2020 as compared to the three months ended September 29, 2018,28, 2019, primarily due to lower shipments of our mobile products and base station products to Huawei as well as lowerhigher demand for our mobile products in support of oursmartphone customers based in China. These decreases were partially offset by increased revenue resulting fromChina and Korea, higher demand for marquee smartphones experienced by our largest end customer as well as5G base station products (primarily in China), and higher demand from a Korea-based customer.for our Wi-Fi products.

Revenue was flatincreased for the six months ended September 28, 2019,October 3, 2020 as compared to the six months ended September 29, 2018, with increased revenue resulting from28, 2019, primarily due to higher demand for marquee smartphones experienced by our largest end customer as well as5G base station products (primarily in China), higher demand from a Korea-based customer, being offset by lower demand for our mobile products in support of smartphone customers based in China.

During the six months ended September 28, 2019, we temporarily suspendedChina and Korea, and higher demand for our Wi-Fi products, partially offset by lower shipments of our mobile products to Huawei afterTechnologies Co., Ltd. and affiliates ("Huawei").

On May 16, 2019, the Bureau of Industry and Security ("BIS") of the U.S. Department of Commerce ("Commerce") added Huawei Technologies Co., Ltd. and over 100 of its affiliates to the BIS's Entity List.  Eventually,List maintained by Commerce, which caused us to temporarily suspend the shipment of all products to Huawei. In August 2020, Commerce issued a final rule adding additional Huawei non-U.S. affiliates to the Entity List, confirming the expiration of a temporary general license applicable to Huawei, and amending the foreign-produced direct product rule in a manner that represents a significant expansion of its application to Huawei. While we restarted shipments to Huawei of certain products from outside the U.S. of certain foreign-made products that arewere not subject to the Export Administration Regulations ("EAR") to Huaweiin fiscal 2020, during the second quarter of fiscal 2021, as a result of and in compliance with the BIS order. Wemost recent Commerce action, we suspended shipments of products to Huawei. While we have also applied forobtained a license to allow us to ship othercertain mobile products that are subject toin compliance with the EAR, as required by the rules governing the Entity List.

Consistent withmost recent Commerce action, our prior disclosure, we recognized significantly lower sales to Huawei in the three months ended September 28, 2019 (approximately 5.0% of our total revenue) as comparedwill continue to the three months ended June 29, 2019 (approximately 22.0% of our total revenue).be impacted by trade restrictions.

Gross margin was flatincreased for the three months ended September 28, 2019October 3, 2020 as compared to the three months ended September 29, 2018, with gross margin improvements related28, 2019, primarily due to overall favorable factory utilization, lower intangible amortization expenseinventory adjustments and favorable changes in product mix beinglower restructuring charges, partially offset by lower factory utilization and increased restructuring charges.average selling price erosion.

Gross margin increased for the six months ended October 3, 2020 as compared to the six months ended September 28, 2019, was 39.0%, as compared to 37.4% the six months ended September 29, 2018. This increase was primarily due to lower intangible amortization expense, favorable changes in product mix, overall favorable factory utilization and lower manufacturing costs,restructuring charges, partially offset by increased restructuring charges, average selling price erosion and lower factory utilization.erosion.

Operating Expenses

Research and development expense was relatively flatincreased for the three and six months ended October 3, 2020 as compared to the three and six months ended September 28, 2019, primarily due to higher personnel costs and increased product development spend resulting from our recent acquisitions.

Selling, general and administrative expense increased for the three and six months ended October 3, 2020 as compared to the three and six months ended September 28, 2019, primarily due to higher personnel costs and higher intangible amortization expense as a result of our recent acquisitions.

Other operating expense decreased for the three months ended September 28, 2019October 3, 2020 as compared to the three months ended September 29, 2018, with lower product development spend being28, 2019, primarily due to gains realized on the sale of fixed assets, partially offset by the addition of Active-Semiincreased acquisition and integration-related expenses. Research and developmentOther operating expense increased $6.9 million, or 3.0%,decreased for the six months ended September 28, 2019October 3, 2020 as compared to the six months ended September 29, 2018,28, 2019, primarily due to higher personnel costsgains realized on the sale of fixed assets and the addition of Active-Semi expenses, partially offset by lower product development spend.

Selling, general and administrative expense decreased $51.2 million, or 36.7%, for the three months ended September 28, 2019 as compared to the three months ended September 29, 2018, primarily due to lower intangible amortization. Selling, general and administrative expense decreased $98.2 million, or 35.6%, for the six months ended September 28, 2019 as compared to the six months ended September 29, 2018, primarily due to lower intangible amortization, partially offset by higher personnel costs and the addition of Active-Semi expenses.

Other operating expense was flat for the three months ended September 28, 2019 as compared to the three months ended September 29, 2018. Other operating expense increased $22.2 million for the six months ended September 28, 2019 as compared to the six months ended September 29, 2018, primarily due to expenses related to the acquisition of Active-Semi as well as restructuring expenses. These costs were partially offset by lower start-up costs as compared to the six months ended September 29, 2018.

Segment Product Revenue, Operating Income and Operating Income as a Percentage of Revenue

Mobile Products
 Three Months Ended Three Months Ended
(In thousands, except percentages) September 28,
2019
 September 29,
2018
 Decrease 
Percentage
Change
 October 3,
2020
 September 28,
2019
 Increase 
Percentage
Change
Revenue $623,106
 $666,539
 $(43,433) (6.5)% $754,294
 $623,106
 $131,188
 21.1%
Operating income 193,431
 196,948
 (3,517) (1.8) 262,858
 193,431
 69,427
 35.9
Operating income as a % of revenue 31.0% 29.5%     34.8% 31.0%    
                
 Six Months Ended Six Months Ended
(In thousands, except percentages) September 28,
2019
 September 29,
2018
 Increase 
Percentage
Change
 October 3,
2020
 September 28,
2019
 Increase 
Percentage
Change
Revenue $1,179,359
 $1,152,618
 $26,741
 2.3 % $1,222,698
 $1,179,359
 $43,339
 3.7%
Operating income 333,366
 286,119
 47,247
 16.5
 372,841
 333,366
 39,475
 11.8
Operating income as a % of revenue 28.3% 24.8%     30.5% 28.3%    

MP revenue decreased $43.4 million, or 6.5%,increased for the three months ended September 28, 2019October 3, 2020 as compared to the three months ended September 29, 2018,28, 2019, primarily due to lower shipments to Huawei as well as lowerhigher demand for our mobile products in support of smartphone customers based in China. These decreases were partially offset by increased revenue resulting from higher demand for marquee smartphones experienced by our largest end customer as well as higher demand from a Korea-based customer.China and Korea.

MP revenue increased $26.7 million, or 2.3%, for the six months ended September 28, 2019October 3, 2020 as compared to the six months ended September 29, 2018,28, 2019, primarily due to increased revenue resulting from higher demand for marquee smartphones experienced by our largest end customer as well as higher demand from a Korea-based customer as well as higher demand from Huawei (which resulted from content expansion). These increases were partially offset by lower demand for our mobile products in support of smartphone customers based in China.China and Korea, partially offset by lower shipments of our mobile products to Huawei.

MP operating income as a percentage of revenue was relatively flatincreased for the three months ended September 28, 2019October 3, 2020 as compared to the three months ended September 29, 2018.28, 2019, primarily due to higher revenue and higher gross margin, partially offset by higher operating expenses. Gross margin was positively impacted by higher factory utilization and favorable changes in product mix, partially offset by average selling price erosion. Operating expenses increased primarily due to higher personnel costs and increased product development spend as a result of recent acquisitions.


MP operating income increased $47.2 million, or 16.5%, for the six months ended September 28, 2019October 3, 2020 as compared to the six months ended September 29, 2018,28, 2019, primarily due to higher gross margin lower operating expenses and higher revenue.revenue, partially offset by higher operating expenses. Gross margin was positively impacted by favorable changes in product mix and lower manufacturing costs, partially offset by average selling price erosion and lower factory utilization.erosion. Operating expenses decreasedincreased primarily due to lowerhigher personnel related costs and lowerincreased product development spend.spend as a result of recent acquisitions.


Infrastructure and Defense Products

Three Months Ended
Three Months Ended
(In thousands, except percentages)
September 28,
2019

September 29,
2018

Decrease
Percentage
Change

October 3,
2020

September 28,
2019

Increase
Percentage
Change
Revenue
$183,592

$217,904

$(34,312)
(15.7)%
$305,998

$183,592

$122,406

66.7%
Operating income
14,969

56,311

(41,342)
(73.4)
66,495

14,969

51,526

344.2
Operating income as a % of revenue
8.2%
25.8%




21.7%
8.2%



                
 Six Months Ended Six Months Ended
(In thousands, except percentages) September 28,
2019
 September 29,
2018
 Decrease Percentage
Change
 October 3,
2020
 September 28,
2019
 Increase Percentage
Change
Revenue $402,937
 $424,495
 $(21,558) (5.1)% $625,045
 $402,937
 $222,108
 55.1%
Operating income 65,093
 111,515
 (46,422) (41.6) 160,250
 65,093
 95,157
 146.2
Operating income as a % of revenue 16.2% 26.3%     25.6% 16.2%    

IDP revenue decreased $34.3 million, or 15.7%,increased for the three and six months ended September 28, 2019October 3, 2020 as compared to the three months ended September 29, 2018, primarily due to lower demand for our base station products from Huawei as well as lower demand for our Wi-Fi products. These decreases were partially offset by sales of our programmable power management products as a result of the acquisition of Active-Semi.

IDP revenue decreased $21.6 million, or 5.1%, for theand six months ended September 28, 2019, as compared to the six months ended September 29, 2018, primarily due to lowerhigher demand for our 5G base station products (primarily in China), and higher demand for our Wi-Fi products, partially offset by sales of our programmable power management products as a result of the acquisition of Active-Semi.products.

IDP operating income decreased $41.3 million, or 73.4%,increased for the three and six months ended October 3, 2020 as compared to the three and six months ended September 28, 2019, as compared to the three months ended September 29, 2018, primarily due to lowerhigher revenue lowerand higher gross margin, andpartially offset by higher operating expenses. Gross margin was negativelypositively impacted by inventory chargeshigher factory utilization and lower factory utilization. The increaseinventory adjustments, partially offset by unfavorable changes in operatingproduct mix. Operating expenses wasincreased primarily due to higher personnel costs and the additionincreased product development spend as a result of Active-Semi expenses.recent acquisitions.

IDP operating income decreased $46.4 million, or 41.6%, for the six months ended September 28, 2019 as compared to the six months ended September 29, 2018, primarily due to higher operating expenses, lower gross margin and lower revenue. The increase in operating expenses was primarily due to higher personnel costs and the addition of Active-Semi expenses. Gross margin was negatively impacted by inventory charges and lower factory utilization.
See Note 1112 of the Notes to Condensed Consolidated Financial Statements for a reconciliation of segment operating income to the consolidated operating income for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018.2019.

INTEREST, OTHER INCOME (EXPENSE) INCOME AND INCOME TAXES
 Three Months Ended Six Months EndedThree Months Ended Six Months Ended
(In thousands)  September 28,
2019
 September 29,
2018
 September 28,
2019
 September 29,
2018
October 3, 2020 September 28, 2019 October 3, 2020 September 28, 2019
Interest expense $(12,693) $(9,689) $(24,557) $(24,042)$(23,486) $(12,693) $(42,335) $(24,557)
Interest income 2,292
 1,580
 5,238
 4,974
1,272
 2,292
 2,462
 5,238
Other expense (300) (49,532) (1,411) (81,487)
Income tax (expense) benefit (19,028) (752) (24,684) 31,384
Other income (expense), net648
 (300) 22,595
 (1,411)
Income tax expense(63,161) (19,028) (63,239) (24,684)


Interest expense
Interest Expense
During the three and six months ended October 3, 2020, we recorded interest expense of $24.6 million and $44.6 million, respectively, which was partially offset by $1.1 million and $2.3 million, respectively, of capitalized interest. During the three and six months ended September 28, 2019, we recorded interest expense of $14.0 million and $27.6 million, respectively, primarily related to the 5.50% senior notes due July 15, 2026 (the "2026 Notes"), which was partially offset by $1.3 million and $3.0 million, respectively, of capitalized interest. Interest expense increased as a result of the issuance of the 4.375% senior notes due October 15, 2029 (the "2029 Notes"). See Note 7 of the Notes to Condensed Consolidated Financial Statements for additional information.

Other income (expense), net
During the three and six months ended September 29, 2018,October 3, 2020, we recorded interest expense of $11.5 million and $29.3 million, respectively, primarily related to the 6.75% senior notes due December 1, 2023 (the "2023 Notes"), the 7.00% senior notes due December 1, 2025 (the "2025 Notes") and the 2026 Notes, which was partially offset by $1.8 million and $5.3$0.1 million of capitalized interest.

Other Expense
During the threeexpense and six months ended September 29, 2018, we recorded a loss$15.6 million of income, respectively, based on debt extinguishment of $48.8 million and $82.2 million, respectively, in connection with certain purchasesour share of the 2023 Notes and the 2025 Notes.earnings from our investments in two limited partnerships.

Income Taxestax expense
Our provision for income taxes for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018 washas been calculated by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pre-tax income or loss excluding unusual or infrequently occurring discrete items) for those respective periods.

For the three and six months ended October 3, 2020, we recorded income tax expense of $63.2 million, which was comprised primarily of tax expense related to international operations generating pre-tax book income, and discrete tax items recorded

during the period. The discrete tax expense items primarily relate to the intercompany restructuring of the Cavendish Kinetics Limited intellectual property, partially offset by discrete tax benefits recognized for stock-based compensation deductions and a retroactive incentive allowing previously non-deductible payments to be amortized. For the three and six months ended September 28, 2019, we recorded income tax expense of $19.0 million and $24.7 million, respectively, which was comprised primarily of tax expense related to international operations generating pre-tax book income and the reversal of the permanent reinvestment assertion with regards to unrepatriated foreign earnings, partially offset by a tax benefit related to domestic and international operations generating pre-tax book losses and domestic tax credits. For the three and six months ended September 29, 2018, we recorded income tax expense of $0.8 million and income tax benefit of $31.4 million, respectively, which was comprised primarily of tax benefit related to domestic and international operations generating pre-tax book losses, a tax incentive granted in Singapore and adjustments in the provisional estimates required by the Tax Cuts and Jobs Act, offset by a tax expense related to international operations generating pre-tax book income.

A valuation allowance remained against certain domestic and foreign net deferred tax assets as it is more likely than not that the related deferred tax assets will not be realized.

During the second quarter of fiscal 2020, we determined that we could no longer support a permanent reinvestment position on certain earnings previously subject to U.S. federal taxation at our foreign subsidiaries. This change was primarily a result of future cash flow projections outside the U.S. and implementation of a more centralized approach to cash management.

LIQUIDITY AND CAPITAL RESOURCES

Cash generated by operations is our primary source of liquidity. As of September 28, 2019,October 3, 2020, we had working capital of approximately $1,102.2$1,585.7 million, including $586.8$2,000.3 million in cash and cash equivalents, compared to working capital of approximately $1,249.2$1,151.5 million, at March 30, 2019, including $711.0$714.9 million in cash and cash equivalents. The decrease in working capital was primarily due to the acquisitionequivalents as of Active-Semi. This decrease in working capital was partially offset by the $100.0 million draw on the Term Loan in the first quarter of fiscalMarch 28, 2020.

The cash balance at October 3, 2020 includes $700.0 million from the issuance of the 2031 Notes which was used subsequent to quarter end (combined with cash on hand and the $200.0 million draw under the 2020 Term Loan) to redeem the $900.0 million principal balance of the 2026 Notes. The principal balance of the 2026 Notes was reclassified as of October 3, 2020, from "Long-term debt" to "Current portion of long-term debt" in the Condensed Consolidated Balance Sheet due to our intention to retire the obligation soon after the balance sheet date. See Note 15 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the redemption of the 2026 Notes.
Our $586.8$2,000.3 million of total cash and cash equivalents as of September 28, 2019October 3, 2020 includes approximately $503.5$617.0 million held by our foreign subsidiaries, of which $424.0$512.7 million is held by Qorvo International Pte. Ltd. in Singapore. If the undistributed earnings of our foreign subsidiaries are needed in the U.S., we may be required to pay state income and/or foreign local withholding taxes to repatriate these earnings. 

Stock Repurchases
During the six months ended September 28, 2019,October 3, 2020, we repurchased approximately 3.81.6 million shares of our common stock for approximately $265.1$180.0 million under our share repurchase program. As of September 28, 2019, $132.8October 3, 2020, approximately $585.9 million remained available for repurchases under the program.

On October 31, 2019, we announced that our Board of Directors authorized a new share repurchase program. See Note 15 of the Notes to Condensed Consolidated Financial Statements for information regarding the new share repurchase program.


Cash Flows from Operating Activities
Operating activities for the six months ended September 28, 2019October 3, 2020 generated cash of $430.5$495.2 million, compared to $289.8$430.5 million for the six months ended September 29, 2018,28, 2019, primarily due to favorableincreased profitability, partially offset by changes in working capital driven by improvements in days sales outstanding as well as the timing of sales during the six months ended September 28, 2019.accounts receivable.

Cash Flows from Investing Activities
Net cash used in investing activities was $111.3 million for the six months ended October 3, 2020, compared to $387.3 million for the six months ended September 28, 2019, compared to $132.82019. During the six months ended October 3, 2020, we acquired 7Hugs for $47.7 million for(net of cash acquired). During the six months ended September 29, 2018, primarily due28, 2019, we acquired Active-Semi International, Inc. for $299.7 million (net of cash acquired). See Note 4 of the Notes to the acquisition of Active-Semi.Condensed Consolidated Financial Statements for additional information regarding our business acquisitions.

Cash Flows from Financing Activities
Net cash used inprovided by financing activities was $900.4 million for the six months ended October 3, 2020, compared to $166.3 million of net cash used by financing activities for the six months ended September 28, 2019, compared to $523.0 million for the six months ended September 29, 2018.2019. During the six months ended September 29, 2018, cash disbursed in connection with the retirement of all of the 2023 Notes and a majority of the 2025 Notes was partially offset by cashOctober 3, 2020, we received proceeds received from (1) the issuance of an additional $300.0 million aggregate principal amount of the 2026 Notes. During2029 Notes, (2) the issuance of $700.0 million aggregate principal amount of the 2031 Notes, and (3) the $200.0 million draw under the 2020 Term Loan. In addition, during the six months ended September 28, 2019,October 3, 2020, we drewmade payments of $100.0 million on the term loan (the "2017 Term Loan") under our Term Loan.previous credit agreement dated as of December 5, 2017 (the "2017 Credit Agreement").

COMMITMENTS AND CONTINGENCIES

2023Credit AgreementOn September 29, 2020, we and certain of our U.S. subsidiaries (the “Guarantors”) entered into a five-year unsecured senior credit facility pursuant to a credit agreement (the "2020 Credit Agreement") with Bank of America, N.A.

acting as administrative agent and a syndicate of lenders. The 2020 Credit Agreement amended and restated the 2017 Credit Agreement. The 2020 Credit Agreement includes a senior term loan (the "2020 Term Loan") of up to $200.0 million and a senior revolving line of credit (the "Revolving Facility") of up to $300.0 million (collectively the “Credit Facility”).

On the closing date of the 2020 Credit Agreement, we repaid the remaining principal balance of $97.5 million on the 2017 Term Loan and concurrently drew $200.0 million under the 2020 Term Loan. Interest paid on the 2017 Term Loan during the three and six months ended October 3, 2020 was $0.4 million and $0.8 million, respectively.

Pursuant to the 2020 Credit Agreement, we may request one or more additional tranches of term loans or increases in the Revolving Facility, up to an aggregate of $500.0 million and subject to securing additional funding commitments from the existing or new lenders. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Credit Facility is available to finance working capital, capital expenditures and other lawful corporate purposes. Outstanding amounts are due in full on the maturity date of September 29, 2025, subject to scheduled amortization of the 2020 Term Loan principal prior to the maturity date as set forth in the 2020 Credit Agreement. During the six months ended October 3, 2020, there were no borrowings under the Revolving Facility.

The 2020 Credit Agreement contains various conditions, covenants and representations with which we must be in compliance in order to borrow funds and to avoid an event of default. As of October 3, 2020, we were in compliance with these covenants.

See Note 7 of the Notes and to Condensed Consolidated Financial Statements for additional information regarding the 2020 Credit Agreement.

2025 Notes On November 19, 2015, we issued $450.0 million aggregate principal amount of the 2023 Notes and $550.0 million aggregate principal amount of our 7.00% senior notes due December 1, 2025 (the "2025 Notes"). Interest on the 2025 Notes.Notes is payable on June 1 and December 1 of each year. The 2023 Notes were, and the 2025 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by certain of our U.S. subsidiaries (the "Guarantors"). With respect to the 2023 Notes, interest was payable semi-annually on June 1 and December 1 of each year at a rate of 6.75% per annum, and with respect to the 2025 Notes, interest is payable on June 1 and December 1 of each year at a rate of 7.00% per annum. We paid no interest on the 2025 Notes during the three months ended September 28, 2019 and we paid interest of $0.8 million on the 2025 Notes during the six months ended September 28, 2019. Interest paid on the 2023 Notes and the 2025 Notes during the three and six months ended September 29, 2018 was $7.3 million and $41.5 million, respectively.Guarantors.

In fiscal years 2018 and 2019, we retired all of the issued and outstanding 2023 Notes and $526.6 million of the 2025 Notes.  As of September 28, 2019,October 3, 2020, an aggregate principal amount of $23.4 million of the 2025 Notes remained outstanding.

See Note 7 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the 2023 Notes and the 2025 Notes.

2026 Notes On July 16, 2018, we issued $500.0 million aggregate principal amount of the 2026 Notes (the "Initial 2026 Notes").Notes. On August 28, 2018 and March 5, 2019, we completed offerings ofissued an additional $130.0 million and $270.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2026 Notes", and together with the Initial 2026 Notes, the "2026 Notes"). The 2026 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by each of the Guarantors.Notes. Interest on the 2026 Notes is payable on January 15 and July 15 of each year at a rate of 5.50% per annum. Interest paid on theThe 2026 Notes duringare senior unsecured obligations of the threeCompany and six months ended September 28, 2019 was $24.8 million.are guaranteed, jointly and severally, by the Guarantors.

In connection with the offerings of the 2026 Notes, we agreed to provide the holders of the 2026 Notes with an opportunity to exchange the 2026 Notes for registered notes having terms substantially identical to the 2026 Notes. On June 25, 2019,October 16, 2020, we completed the exchange offer, in whichredemption of all of the privately placedoutstanding 2026 Notes were exchangedat a redemption price equal to 106.363% of the principal amount of $900.0 million (plus and accrued and unpaid interest), for new notes that have been registered under the Securities Acta total cash payment of 1933, as amended (the "Securities Act").$969.8 million.

See Note 7 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the 2026 Notes.

2029 Notes On September 30, 2019, we issued $350.0 million aggregate principal amount of the 4.375% senior notes due October 15, 2029 (the "2029 Notes"). TheNotes. On December 20, 2019 and June 11, 2020, we issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of the 2029 Notes were sold in a private offering to certain institutions that then resoldNotes. Interest on the 2029 Notes in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Actis payable on April 15 and to certain non-U.S. persons in accordance with Regulation S under the Securities Act. We intend to use the net proceedsOctober 15 of the offering for general corporate purposes.each year at a rate of 4.375% per annum. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by each of the Guarantors.

Interest on the 2029 Notes is payable on October 15 and April 15 of each year at a rate of 4.375% per annum.

See Note 157 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the 2029 Notes.


Credit Agreement2031 Notes On December 5, 2017,September 29, 2020, we and the Guarantors entered into a five-year unsecured senior credit facility with Bank of America, N.A., as administrative agent, swing line lender, and L/C issuer, and a syndicate of lenders (the “Credit Agreement”). On the same date, in connection with the executionissued $700.0 million aggregate principal amount of the Credit Agreement, we terminated our prior credit agreement, dated2031 Notes. Interest on the 2031 Notes is payable on April 7, 2015.1 and October 1 of each year, commencing April 1, 2021, at a rate of 3.375% per annum. The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by the Guarantors.

The Credit Agreement includes a senior delayed draw term loan of up to $400.0 million (the "Term Loan") and a $300.0 million revolving line of credit (the "Revolving Facility", together with the Term Loan, the "Credit Facility"). On the closing date, $100.0 million of the Term Loan was funded, and this amount was subsequently repaid in March 2018. On June 17, 2019, we drew $100.0 million of the Term Loan, with the remaining $200.0 million available, at our discretion, in a final draw. Subsequent amendments to the Credit Agreement have, among other things, extended the delayed draw availability period to December 31, 2019. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. We may request at any time that the Credit Facility be increased up to $300.0 million. The Credit Facility is available to finance working capital, capital expenditures and other corporate purposes. Our obligations under the Credit Agreement are jointly and severally guaranteed by the Guarantors. Outstanding amounts are due in full on the maturity date of December 5, 2022 (with amounts borrowed under the swing line option due in full no later than ten business days after such loan is made). During the three and six months ended September 28, 2019, there were no borrowings under the Revolving Facility. Interest paid on the Term Loan during the three and six months ended September 28, 2019 was $0.9 million.

The Credit Agreement contains various conditions, covenants and representations with which we must be in compliance in order to borrow funds and to avoid an event of default. As of September 28, 2019, we were in compliance with all the financial covenants under the Credit Agreement.

See Note 7 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the Credit Agreement.2031 Notes.

Capital Commitments At September 28, 2019,October 3, 2020, we had capital commitments of approximately $52.2$62.2 million primarily for projects related to GaN technology capabilities, premium filtermanufacturing capacity, and manufacturing cost savings initiatives, as well as for equipment replacementsupgrades and general corporate purposes.


Future Sources of Funding Our future capital requirements may differ materially from those currently anticipatedprojected and will depend on many factors, including the long-term impact of the COVID-19 pandemic on our business (including our supply chain), financial conditions, results of operations, cash flow, as well as market acceptance of and demand for our products, acquisition opportunities, technological advances and our relationships with suppliers and customers. Based on current and projected levels of cash flow from operations, coupled with our existing cash, and cash equivalents and our Credit Facility, we believe that we have sufficient liquidity to meet both our short-term and long-term cash requirements. However, if there is a significant decrease in demand for our products, or in the event that growth is faster than we anticipate, operating cash flows may be insufficient to meet our needs. If our existing resources andliquidity combined with cash from operations are not sufficient to meet our future requirements or if we perceive conditions to be favorable, we may seek additional debt or equity financing. We cannot be sure that any additional equitydebt or debtequity financing will not be dilutive to holders of our common stock. Further, we cannot be surestock or that additional equitydebt or debtequity financing, if required, will be available on favorable terms, if at all.

Legal We are involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. These actions, when finally concluded and determined, will not, in the opinion of management, have a material adverse effect on our consolidated financial position or results of operations.

Taxes We are subject to income and other taxes in the United States and in numerous foreign jurisdictions. Our domestic and foreign tax liabilities are subject to the allocation of revenues and expenses in different jurisdictions. Additionally, the amount of taxes paid is subject to our interpretation of applicable tax laws in the jurisdictions in which we operate. We are subject to audits by tax authorities. While we endeavor to comply with all applicable tax laws, there can be no assurance that a governing tax authority will not have a different interpretation of the law than we do or that we will comply in all respects with applicable tax laws, which could result in additional taxes. There can be no assurance that the outcomes from tax audits will not have an adverse effect on our results of operations in the period during which the review is conducted.

SUPPLEMENTAL PARENT AND GUARANTOR FINANCIAL INFORMATION

In accordance with the indentures governing the 2025 Notes, the 2026 Notes, the 2029 Notes and the 2031 Notes (collectively, the "Notes"), our obligations under the Notes are fully and unconditionally guaranteed on a joint and several unsecured basis by the Guarantors, each of which is 100% owned, directly or indirectly, by Qorvo, Inc. ("Parent"). A Guarantor can be released in certain customary circumstances. Our other U.S. subsidiaries and our non-U.S. subsidiaries do not guarantee the Notes (such subsidiaries are referred to as the "Non-Guarantors").

The following presents summarized financial information for the Parent and the Guarantors on a combined basis as of and for the period indicated, after eliminating (i) intercompany transactions and balances among the Parent and Guarantors, and (ii) equity earnings from, and investments in, any Non-Guarantor. The summarized financial information may not necessarily be indicative of the financial position and results of operations had the combined Parent and Guarantors operated independently from the Non-Guarantors.
Summarized Balance Sheet

  
(in thousands) October 3, 2020
Current assets (1)
 $2,101,975
Non-current assets $2,504,778
   
Current liabilities $1,147,002
Long-term liabilities (2)
 $1,969,916
(1) Includes current receivable from Non-Guarantors of $462.0 million.
(2) Includes non-current payable to Non-Guarantors of $83.8 million.
Summarized Statement of Income Six Months Ended
(in thousands) October 3, 2020
Revenue $786,274
Gross profit $364,018
Net income $116,083

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

There have been no material changes to our market risk exposures during the second quarter of fiscal 20202021. For a discussion of our exposure to market risk, refer to Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” contained in Qorvo's Annual Report on Form 10-K for the fiscal year ended March 30, 201928, 2020.

ITEM 4. CONTROLS AND PROCEDURES.

As of the end of the period covered by this report, the Company’s management, with the participation of the Company’s Chief Executive Officer (CEO) and the Chief Financial Officer (CFO), evaluated the effectiveness of the Company’s disclosure controls and procedures in accordance with Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our CEO and CFO concluded that the Company’s disclosure controls and procedures were effective, as of such date, to enable the Company to record, process, summarize and report in a timely manner the information that the Company is required to disclose in its Exchange Act reports, and to accumulate and communicate such information to management, including the Company’s CEO and the CFO, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended September 28, 2019October 3, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Due to the ongoing COVID-19 pandemic, a significant number of our employees are now working from home. The design of our processes, systems, and controls allows for remote execution with accessibility to secure data.

PART II — OTHER INFORMATION

ITEM 1A. RISK FACTORS.

Other than the risk factor set forth below, there have been no material changes to the risk factors included in Qorvo’s Annual Report on Form 10-K for the fiscal year ended March 28, 2020. In addition to the risk factor set forth below and the other information set forth in this report and in our other reports and statements that we file with the SEC, including our quarterly reports on Form 10-Q, careful consideration should be given to the factors discussed in Part I, Item 1A., “Risk Factors” in Qorvo's Annual Report on Form 10-K for the fiscal year ended March 30, 2019,28, 2020, which could materially affect our business, financial condition or future results. The risks described in Qorvo's Annual Report on Form 10-K for the fiscal year ended March 30, 2019and Quarterly Reports on Form 10-Q are not the only risks that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Changes in government trade policies, including the imposition of tariffs and export restrictions, have limited and could continue to limit our ability to sell our products to certain customers, which may materially adversely affect our sales and results of operations.

The U.S. or foreign governments have taken and may continue to take administrative, legislative or regulatory action that could materially interfere with our ability to sell products in certain countries, particularly in China. For example, between July 2018 and June 2019, the Office of the United States Trade Representative imposed 25% tariffs on specified product lists, including certain electronic components and equipment, totaling approximately $250 billion in Chinese imports. In response, China imposed or proposed new or higher tariffs on U.S. products. The U.S. government also imposed 15% tariffs on an additional $120 billion of Chinese imports, with China imposing retaliatory tariffs. While the imposition of these tariffs did not have a direct, material adverse impact on our business during fiscal 2020, the direct and indirect effects of tariffs and other restrictive trade policies are difficult to measure and are only one part of a larger U.S./China economic and trade policy disagreement. For example, imposition of tariffs on our customers’ products that are imported from China to the U.S. could harm sales of such products, which would harm our business. We cannot predict what further actions may ultimately be taken with respect to tariffs or trade relations between the U.S. and China or other countries, what products may be subject to such actions, or what actions may be taken by the other countries in retaliation.

Furthermore, we have experienced restrictions on our ability to sell products to certain foreign customers where sales of products require export licenses or are prohibited by government action. The U.S. government has in the past imposed export restrictions that effectively banned American companies from selling products to ZTE Corporation, one of our customers. In May 2019, the Bureau of Industry and Security of the U.S. Department of Commerce (“Commerce”) added Huawei Technologies Co., Ltd. and over 100 of its affiliates to the “Entity List” maintained by Commerce, which caused us to temporarily suspend the shipment of products to Huawei. In August 2020, Commerce issued a final rule adding additional Huawei non-U.S. affiliates to the Entity List, confirming the expiration of a temporary general license applicable to Huawei, and amending the foreign-produced direct product rule in a manner that represents a significant expansion of its application to Huawei. Huawei accounted for 10%, 15% and 8% of our total revenue during fiscal years 2020, 2019, and 2018, respectively. While we restarted shipments to Huawei of certain products from outside the U.S. that were not subject to the Export Administration Regulations (“EAR”) in fiscal 2020, during the second quarter of fiscal 2021, as a result of and in compliance with the most recent Commerce action, we suspended shipments of products to Huawei. While we have obtained a license to allow us to ship certain mobile products in compliance with the most recent Commerce action, our sales to Huawei will continue to be impacted by trade restrictions.

As of the date of this report, we are unable to predict the scope and duration of the export restrictions imposed on Huawei and the corresponding future effects on our business. Even if such restrictions are lifted, any financial or other penalties or continuing export restrictions imposed on Huawei could have a continuing negative impact on our future revenue and results of operations. In addition, Huawei or other foreign customers affected by future U.S. government sanctions or threats of sanctions may respond by developing their own solutions to replace our products or by adopting our foreign competitors’ solutions. Moreover, U.S. government actions targeting exports of certain technologies to China are becoming more pervasive. For example, in 2018, the U.S. adopted new laws designed to address concerns about the export of emerging and foundational technologies to China. In addition, in May 2019, an executive order was issued that invoked national emergency economic powers to implement a framework to regulate the acquisition or transfer of information communications technology in transactions that imposed undue national security risks. These actions could lead to additional restrictions on the export of products that include or enable certain technologies, including products we provide to China-based customers.

The loss or temporary loss of Huawei or other foreign customers or the imposition of restrictions on our ability to sell products to such customers as a result of tariffs, export restrictions or other U.S. regulatory actions could materially adversely affect our sales, business and results of operations.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

(c) Issuer Purchases of Equity Securities

Purchases of Equity Securities

Period 
Total number of shares purchased (in thousands)
 Average price paid per share 
Total number of shares purchased as part of publicly announced plans or programs (in thousands)
 Approximate dollar value of shares that may yet be purchased under the plans or programs
June 30, 2019 to July 27, 2019 173
 $70.15
 173
 $285.7 million
July 28, 2019 to August 24, 2019 1,342
 $71.26
 1,342
 $190.1 million
August 25, 2019 to September 28, 2019 786
 $72.78
 786
 $132.8 million
Total 2,301
 $71.70
 2,301
 $132.8 million
Period 
Total number of shares purchased (in thousands)
 Average price paid per share 
Total number of shares purchased as part of publicly announced plans or programs (in thousands)
 Approximate dollar value of shares that may yet be purchased under the plans or programs
June 28, 2020 to August 1, 2020 175
 $110.64
 175
 $671.5 million
August 2, 2020 to August 29, 2020 397
 $131.59
 397
 $619.2 million
August 30, 2020 to October 3, 2020 265
 $126.06
 265
 $585.9 million
Total 837
 $125.46
 837
 $585.9 million

On May 23, 2018,October 31, 2019, we announced that our Board of Directors authorized a new share repurchase program to repurchase up to $1.0 billion of ourthe Company's outstanding stock.common stock, which included approximately $117.0 million authorized under the prior program which was terminated concurrent with the new authorization. Under this program, share repurchases will beare made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which we repurchase our shares, the number of shares and the timing of any repurchases will dependdepends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require us to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice.

On October 31, 2019, we announced that our Board of Directors authorized a new share repurchase program. See Note 15 of the Notes to Condensed Consolidated Financial Statements for information regarding the new share repurchase program.

ITEM 6. EXHIBITS.
 
4.1
10.1
31.1
  
31.2
  
32.1
  
32.2
  
101
The following materials from our Quarterly Report on Form 10-Q for the quarter ended September 28, 2019,October 3, 2020, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of September 28, 2019October 3, 2020 and March 30, 2019;28, 2020; (ii) the Condensed Consolidated Statements of Income for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018;2019; (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018;2019; (iv) the Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended October 3, 2020 and September 28, 2019 and September 29, 2018;2019; (v) the Condensed Consolidated Statements of Cash Flows for the six months ended October 3, 2020 and September 28, 2019 and September 29, 2018;2019; and (vi) the Notes to Condensed Consolidated Financial Statements
  
104
The cover page from our Quarterly Report on Form 10-Q for the quarter ended September 28, 2019,October 3, 2020, formatted in iXBRL

Our SEC file number for documents filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended, is 001-36801.


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
   Qorvo, Inc.
    
Date:November 1, 20195, 2020 /s/ Mark J. Murphy
   Mark J. Murphy
   Chief Financial Officer
    
    
    
    


4134